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CHAPTER I INTRODUCTION,
INTRODUCTION 
1.Ô Adaptive Growth
Adaptive growth can be caused in a variety of ways.
In many organs, for example liver, a reduction in mass by 
surgical excision calls forth a growth response in what 
remains (Glinos 1958). The same sort of response may often 
be elicited by creating a functional overload without 
diminishing the substance of the organ* The nature of this 
functional overload varies from organ to organ depending 
upon what physiological activitié^S are normally carried out. 
Apparently all that is necessary is to create an imbalance 
between functional demands and the capacity of the organ in 
question to meet them.
It has been suggested (Goss, 1966-67) that the way in 
which growth is achieved depends largely on the kind of 
organ and the level of organisation. Some organs can 
increase their mass by adding new units at the histological 
level of organisation. New follicles, for example, can be 
added to the thyroid (Gray, 1929), the ovary (Greenwald, 
1962) and the exocrine glands (Augustine, 196 3). Other 
organs, unable to produce such complicated structures, 
enlarge solely by cellular proliferation. The kidney for 
instance, cannot make new nephrons, but can enlarge those 
it has by multiplying and enlarging their component cells, 
(Bucher and Malt, 1971) .
In like manner, the lungs, which cannot make new 
alveoli beyond infancy, increase their size by cell division 
(Goss, 1964), Cell replication is also the mode of growth 
characteristic/.,.
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characteristic of such renewing tissues as blood, epidermis, 
intestinal mucosa and the spermatogonie epithelial lining 
of seminiferous tubules. Finally, there are some tissues 
and organs which are incapable of multiplying their function­
al units at the histological or cellular level of organisat­
ion, Such a mitotically static tissue mass relies on 
molecular turnover in order to renew itself. This sub- 
cellular renewal is the basis for growth in the nervous 
system {Messier et al, 1958), skeletal muscle (Goldberg,
19 69) and heart muscle (Karsnar et al, 1925). Here the
capacity for compensatory growth is limited to cellular 
hypertrophy. Although such a mechanism provides the 
additional inyiorphological substrate for doing extra work, the 
extent of compensatory growth in such organs is considerably 
restricted owing to the impossibility of mitotic prolifera­
tion, and the upper limit beyond which a cell cannot enlarge 
without an increase in DNA,
2.0 General Introduction
2.1 Cardiac Hypertrophy; of the two adaptations of the
heart to increased work - acceleration in rate (hyperfunct­
ion) } and hypertrophy - the last-named is more readily 
apparent. That hypertrophy resurts from increased work of 
the heart was appreciated by Carvisart (1811), who drew an 
analogy between "active aneurysm", as it was then known, and 
the massive arm of the blacksmith. Subsequent work has con­
firmed the belief that the mass of the myocardium is a 
function of the work it performs. The supporting evidence 
has/...
“■ 3
has been derived from hearts in the diseased state.
The most universal manifestation of heart disease, 
whatever its cause, is cardiac enlargement. Although it 
may not always be present in heart disease, its presence 
always indicates a diseased heart.
Freidbert and Sohval (1937) have classified the 
various factors which result in cardiac hypertrophy as :
(1) those which increase the resistance to 
outflow from the heart (i.e. hypertension, 
valvular disorder and coarctation of the 
aorta),
(2) those which increase in flow to the heart 
(i.e, thyrotoxicosis and anaemia),
(3) those which produce severe myocardial 
weakness (i.e. inflammatory and toxic 
diseases and myocardial infarction).
The common factor associated with these three 
classifications appears to be work.
The process of cardiac hypertrophy can perhaps be 
divided into two stages ? hyperfunction and hypertrophy 
proper. In compensatory hyperfunction the organism makes 
use of the mechanisms of adaptation to physical work which 
have been developed in the process of evolution. At the 
same time however, there is a clear distinction between 
physiological hyperfunction of the heart on the one hand and 
compensatory hyperfunction on the other. This is determined 
not only by the cause of the hyperfunction but also by a 
time/,,.
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time factor. Hyperfunction in a healthy organism reacting 
to a given physiological stress is always temporary and 
discontinuous. It ceases after the completion or cessation 
of the physiological task. Compensatory hyperfunction in 
response to hypertension or valvular disease, on the other 
hand, is not only long-lasting, but what is more important, 
continuous; and the continuity of the compensatory hyper­
function which results is a vital necessity.
In spite of its continuity, compensatory hyperfunction 
of the heart may last for many years without signs of 
exhaustion. At first it is maintained by the existing myo­
cardium, but this leads quite rapidly to the development of 
cardiac hypertrophy and the gradual exhaustion of the heart 
and of its regulatory mechanisms. It is this exhaustion 
which is manifested as the syndrome of chronic heart failure.
Thus, compensatory hyperfunction, hypertrophy and the 
subsequent exhaustion of the hypertrophied heart represent 
links in a single process,
3.0 Structural Changes During Cardiac Hypertrophy
3.1 Histological Changes
The writers of pathology textbooks from the middle of 
the 19th century regarded cardiac hypertrophy as predominant­
ly hyperplasia (i.e. an increase in the number of fibers, 
Forster, 1856). However, even at that time, some investigat­
ors noted that there was no evidence for muscle fiber 
multiplication (Hirtl, 1855) and later studies showed that 
the diameter of normal human heart fiber is 15/jj while in the 
hypertrophied/,.,
hypertrophied heart it is 25/Ato 30^  ^(Letull, 1897),
With the development of more accurate methods for 
counting muscle fibers, Linzback (1947, 1948, 1952, 1955) 
concluded that no division of muscle fibers occurred when 
myocardial mass was increased up to 60%. At greater levels 
of hypertrophy Linzback believed that muscle fibers began to 
divide, and hyperplasia did take placCo These last 
observations, however, are at variance with the findings of 
a majority of other investigations, particularly those of 
Wearn (1939-40) who showed in extensive autopsy and experi­
mental material that muscle fiber size increased in myo­
cardial hypertrophy without any alteration in the number of 
fibers.
Black-'Schaffer and Turner (1958) estimated the 
frequency of nuclei in the myocardium and concluded that myo­
cardial hypertrophy is associated with a reduction in the 
frequency of nuclei. This supports the idea that cardiac 
hypertrophy is not accompanied by multiplication of existing 
muscle cells.
Wearn, (19 39, 19 40) studying the hypertrophied human 
heart, found that the ratio between the number of muscle 
fibers and the number of capillaries in the myocardium was 
the same as in normal hearts (1:24) though the diameter of 
the myocardial fibers increased from 15/U to 26/ji„ This, of 
course, would indicate that there had been no multiplication 
of capillaries to serve the greatly enlarged muscle fibers.
In addition, Woods (1961) compared the cross-sectional area 
of/...
of the right coronary artery with the weight of the total 
ventricular myocardium which it supplied and concluded 
that it did not increase as the ventricle hypertrophied. 
This, like the reduction in the number of capillaries per 
unit mass of myocardium, may limit the supply of oxygen 
and other substrates to the central portion of the muscle 
fibers.
Several authors have described the development of 
fibrosis in the hypertrophied myocardium and generally 
considered it to result from connective tissue replace­
ment of necrotic and degenerative myocardial fibers.
Vail (1939) described areas of necrosis and foci of fatty 
degeneration in human hypertrophied myocardium. Krymkii
(1962) studied 135 children and adolescents with congenital 
heart disease, and found diffuse or focal myocardial 
fibrosis in 134 cases. Earlier case studies by Jacobi 
(1928) and Moenckebert (1924) had indicated that fibrosis 
only occurred when dilation accompanied hypertrophy. 
Schoenmacher (1958) studied the relationship between muscle 
fibers and connective tissue by photomicrography of trans­
verse sections of the myocardium. They found that muscle 
fibers in the left ventricle of tne normal heart occupied 
92% of the area of section and connective tissue only 8%.
In chronic aortic insufficiency, connective tissue occupied 
48% of the section and muscle fibers only 52%, These 
results taken together indicate that muscle degeneration 
with subsequent fibrosis is a characteristic of hypertrophy 
3 . 2 / . . .
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3.2 Morphological Changes in the Myocardial Cell
The morphology of the hypertrophied myocardial cell 
began to be studied only after the introduction of the 
electron microscope. There are several main ultra- 
structural changes in the hypertrophied hearts;-
(1) The sarcolemma. Studied by Poche (196 9) 
and Dowlatshahi et al, (196 9) of hypertrophied 
hearts have shown that, in cases where 
individual myocardial cells have enlarged to 
twice their normal size, an increase occurs in 
the amount of subsarcoleimmal sarcoplasm. This 
increase in sarcoplasm was associated with a 
high degree of vésiculation of the sarcolemmal 
membranes. Other ultrastructural investigators 
of cardiac hypertrophy have noted sarcolemmal 
vésiculation (Bozner et al, 1966) describing 
them as "cardiac villi" or "arcade-like 
diverticulae". Often ribosomes, sarcoplasm 
andHif'iPchondria filled these diverticulae^ and 
multiple pinocytotic vesicles were seen in 
close approximation to either surface of the 
sarcolemmal membranes. Such modifications in 
the sarcolemma may reflect the need of the 
hypertrophied cell for an increased surface 
area. The presence of mitochondria in these 
villus-like processes, as well as the multi­
plicity of pinocytotic vesicles, may indicate 
hyperfunction/...
hyperfuriction of active transport mechanisms.
(2) The Sarcotubular System. Most 
observers of hypertrophied hearts have noted 
dilatation of the sarcoplasmic reticulum and 
T-tubules, components of the sarcotubular 
system (Meessen, 19 68). These changes in 
area may make possible an increase in the 
level of electrolyte transport to maintain 
the excitation/ionic conduction relationship 
of the normal fiber.
(3) Nuclei, In hypertrophy, an increase 
occurs in the cellular volume supplied by 
each nucleus. There is a concomitant but 
smaller increase in nuclear size (Linzback 
19 62); further, the nuclear membrane has 
often been seen to have numerous indentations 
(Poche, 1969).
(4) Intercalated Disc. Increase in the 
width of the intercellular gap region of the 
intercalated disc and vésiculation exhibiting 
a dense matrix have been observed by Bishop 
et al, (1969) and Sohal et al, (1968) . It 
was suggested that hypertrophy and vésiculation 
of the gap structure might result in an 
alteration in the efficiency of electrical 
excitation affecting ultimately the force of 
contraction.
(5)/. , .
(5) Mitochondria. Alterations have been 
reported in
(a) the mitochondrion/myofibril 
ratio and
(b) mitochondrial structure.
A significant decrease in the ratio of 
mitochondria to myofibrils has been observed 
by Palade (1952), Wollenberger et al, (1963) 
and Poche (1969). This might lead, it is 
suggested, to a decline in cardiac efficiency, 
However, other investigators have failed I' to 
detect any such changes and have doubted 
their occurrence (McCallister et al 1962).
The question remains open.
Changes in the structure of the mito­
chondria have been reported by Kirch (19 60), 
Wollenberger etalw(1961) and Novikoff (19 61). 
These have included increases in the width of 
the cristae, fewer cristae in each mito­
chondrion, an increased width of the inter- 
cristae spaces, increases in the width of the 
outer mitochondrial membrane and increa#^s in 
amorphous osmiophilic structure. The 
significance of these changes is unknown.
(6) Myofilaments. The increase in diameter 
of myocardial cells during hypertrophy is 
accompanied by an increase in the number of 
myofilaments/...
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myofilaments (Carney et al,1964, Bishop 
et al 1969, Meessen 1968 and Richter et 
al 19 6 3)o This suggests that fiber, and 
ultimately organ, hypertrophy result from 
a cellular organelle (i.e. myofilament) 
hyperplasia. As the hexagonal pattern of 
thick and thin filaments is reported to be 
unaltered, the suggestion has been advanced 
that the new myofilaments are added at the 
periphery of the myofibrils.
(7) The Z Disc or Band. Structural 
alteration in the disc has been reported by 
Bishop e.t al, (1969) and Fawcett (1968).
This manifested itself as either a focal or 
a general widening of the band. However, 
these changes are sparse and irregular so 
that their functional significance is doubt­
ful.
Apart from these major changes, other ultrastructural 
alterations have been reported including increases in 
glycogen and lysosomal-like granules (lipof;tU:Bhin-granule, 
Pearse 1961, 1971; lipid droplets, Hibbs et al (1965), 
Alexander (1967)).
4.0 Physiology of Cardiac Hypertrophy
4.1 Factors Surrounding Hypertrophy 
When/..,
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When the heart increase^ its level of activity as 
an adaptation to functional overload, the necessary 
adjustment is brought about by two mechanisms:
(a) the Frank-Starling mechanism and
(b) inotropism
Depending on the type and extent of the hyper­
function, either of these mechanisms may play the leading 
role *
(1) In response to physical work in the 
hypoxia of high altitude, in all kinds of 
valvular insufficiency, in arteriovenous 
fistulae, and in anaemia and thyrotoxicosis, 
an increase in cardiac output is obtained 
by an increase in stroke volume and heart 
rate. While systolic tension and ventricular 
pressure also increase , they do so to a 
lesser extent. This type of hyperfunction
is chiefly isotonic,
(2) In systemic and pulmonary hypertension or 
valvular stenosis, hyperfunction of the heart 
maintains cardiac output in spite of increased 
resistance to ventricular ejection. This is 
accomplished by an increase in myocardial wall 
tension and systolic pressure with little or 
no change in stroke volume. This type of 
hyperfunction is chiefly isometric.
Thus it is generally accepted that isotonic hyper­
trophy/, , ,
-12-
hypertrophy results when ventricular volume is increased 
primarily by the Frank-Starling mechanism with inotropism 
playing a secondary role; while isometric hypertrophy 
occurs when myocardial wall tension is increased, primarily 
by the inotropic mechanism with the Frank-Starling mechanism 
in a secondary role (Spiro and Sonnenblick 1965; Sonnenblick 
et al 1962, 1964 and 1965),
4„2 The Functional Significance of Hypertrophy
For many years it has been questioned whether the 
development of myocardial hypertrophy affects the maximum 
strength which the heart is capable of developing (Grant,
196 3). Many investigators have claimed that the hyper­
trophied heart is more efficient than the normal heart 
(Dlechhoff, 1936, Hasenfield and Romberg, 1897). Others, 
however, have believed, on the basis of clinical observations, 
including the well known ST and T wave abnormalities on the 
electrocardiogram, that the hypertrophied heart is always 
functionally inadequate;^and recent investigations have 
clearly established that there is a decrease in the force 
and velocity of contraction in the hypertrophied heart muscle 
(Spann et al, 1966, Beznak, 1958, Korecky, 1966, Geha et al, 
1966 and Meerson, 1969),
Meerson (19 69) has attempted to frame a comprehensive 
theory of both types of hypertrophy. He suggests that in 
isometric hypertrophy the increased wall tension evokes 
increased energy production and protein synthesis and these 
in turn lead to rapid hypertrophy. This, however, is 
succeeded/.,,
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succeeded by a variety of degenerative changes which, 
Meerson believes, reflect exhaustion of the heart's 
functional reserve and of its regulatory mechanisms 
and lead to ultimate failure. In isotonic hyper­
trophy there is little increase in wall tension and, 
therefore, little activation of energy metabolism and 
protein synthesis. Heart failure in this case is, 
according to Meerson, a result of failure to mobilize a 
functional reserve.
5.0 Biochemical Aspects of Cardiac Hypertrophy
5.1 Introduction
Perhaps one might say that every disorder of 
cardiac contractility must find its ultimate explanation 
in a biochemical lesion. Such a lesion during cardiac 
hypertrophy and subsequent failure has been the subject 
of intense investigation during the past few years,
5,20 Energy Production
A defect in energy production was one of the first 
biochemical lesions suspected to underlie the hypertrophied 
failing heart,
5.2.1 Oxidative Phosphorylation
Several reports have described abnormalities in 
oxidative phosphorylation during hypertrophy and subsequent 
failure, (Schwartz and Lee 1962, Wollenberger 1965, Schien 
et al, 1959). Other investigators have found normal 
oxidative phosphorylation in association with heart failure 
(Sobel et al, 1967, Fox and Reed 1965).
Some/...
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Some of these apparent differences may be explained 
by'the differences in the degree of hyperfunction produced 
by these investigators as well as the presence or absence 
of overt heart failure. However, in the presence of 
hypertrophy and heart failure, oxygen consumption remains 
normal (Bing et al, 1963, Olson, 19 59, Levine and Wagman, 
1962) . In addition Bing (1961) on the basis of coronary 
sinus catheterisation has found that the uptake of substrate 
by the myocardium is normal in heart failure.
In comparing experiments in vitro and in vivo it 
must be remembered that any increase in energy metabolism 
seen in vivo is presumably brought about by active myo­
cardial hyperf unction. Ï4hen the heart is removed from the
body this hyperfunction naturally ceases, and, therefore, 
in such cases we are by no means assessing the effects of 
hyperfunction on energy metabolism but rather the influence 
of hyperfunction on the enzyme systems which produce energy. 
Thus it is easy to see that long-lasting hyperfunction 
might be associated with degeneration of mitochondrial 
structures and gradual impairment of the mechanisms by 
which energy is made available for contraction.
However, experiments in vivo are not without their 
own limitations. Firstly, steady state conditions must 
be assumed to prevail in measuring coronary blood flow and- 
consequently, in determining myocardial utilisation of a 
substrate (Zierler, 1961); secondly, the methods provide 
no direct knowledge of the intermediate metabolism of the 
utilised/,.,
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utilised substrate (Bing, 1965); and, finally, the 
quantity of substrate catabolised to CO^ and H^O is 
inferred from an oxygen extraction ratio (Bing et al,
1954). In view of these limitations the metabolism of 
carbohydrates in the hypertrophied failing heart appears 
to require more investigation.
5.2.2 Carbohydrate Metabolism
Little work has been done on carbohydrate metabolism 
in cardiac hypertrophy and heart failure. The few results 
are confusing. Gudjarnason et al„(1964) found increased 
activity of glyceraldehyde phosphate dehydrogenase in the 
myocardium of patients who died with heart failure. This 
may suggest increased use of the glycolytic pathway. Schwartz 
and Lee (1962) found a decrease in anaerobic lactate pro­
duction and glucose utilisation in cell-free supernatant in 
the hypertrophied ventricles of guinea pigs with heart 
failure. However, Bishop et al«, (19 70) found an increase 
in anaerobic glycolysis as measured by lactate production in 
dogs. The possible discrepancy between these two results 
might be explained in the systems used. Schwartz and Lee 
incubated their homogenates with ATP and glucose; whereas 
Bishop et al used ADP, glucose and hexokinase. The 
allosteric effects of adenine nucleotides on the enzymes of 
glycolysis is well known. Other investigators (Meerson 
et al, 1955, Larionov, 1967) have found marked increases 
in vivo in the incorporation of glucose 14C into glycogen 
during cardiac hypertrophy and increased concentrations of 
lactate/...
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lactate and pyruvate. These results suggest an increase 
in anaerobic glycolysis during cardiac hypertrophy,
5.2*3 Lipid Metabolism
Studies using isolated perfused hearts have revealed 
that there is an increase in palmitate uptake with a rise 
in ventricular pressure. Physiological concentrations of 
palmitate also inhibited glucose transport and glycogenolysis 
in hearts with increased ventricular pressure (Neeley et al, 
1969), Studies by Opie (1965).support the findings of 
preferential oxidation of palmitate as compared to glucose 
over a wide range of isovolumic work loads. Carlsten et al,
(1963) , however, l.ic\Veshown that in human hypertrophied 
hearts non-esterfled fatty acids tend to be extracted less 
well than under normal conditions. The discrepancy between 
these findings and those of Neeley and Opie quoted above 
might be explained by a decrease in perfusion in the hyper­
trophied heart due to an increase in the ratio of capillary 
to muscle (Wearn 1940).
iWittlês et al^(1968) measured fatty acids metabolism 
in cardiac hypertrophy and found a decrease in the rate of 
the oxidation of long chain fatty acids by the myocardium. 
They also found an increase in the synthesis of triglycerides 
Although more studies are needed, the balance of 
evidence at present suggests that during cardiac hypertrophy 
there is an increase in glycolysis and a decrease in the 
oxidation of fatty acids,
5.2.4 Energy Storage
Insufficient/...
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Insufficient energy stores for the maintenance of 
normal myocardial contraction have been thought to under­
lie the failure of the hypertrophied heart. Several 
investigators have reported decreased high energy phosphate 
stores during hypertrophy or heart failure (Mangus and 
MyerSf 19 40, Minton et al, 19 60 and Goodkind et al, 19 59, 
Vyalykh and Meerson, 1960, Poole et al, 1967). However, 
the decreasesobserved by most of these investigators were 
smallo
It has been suggested that the failure to find a 
significant relationship between energy stores and the 
onset of heart failure may be due to the fact that energy 
stores are compartmentalised. In this case, a significant 
deletion of a single compartment of energy stores might 
lead to heart failure, but this decrease might not be 
detected when compared to the total store of energy 
(Meerson, 1969) .
5.3 Protein and Nucleic Acid Metabolism
In experimental cardiac hypertrophy and heart 
failure, the total myocardial contents of DNA and RNA are 
increased. The increase in RNA content exceeds the 
increase in myocardial mass and, therefore, myocardial RNA 
concentration is increased. Myocardial DNA content is 
increased more or less in proportion to the increase in 
myocardial size and, therefore, myocardial DNA concentrat­
ion is unchanged (Meerson, 19 69) .
The myocardial cell does not proliferate during the 
process/,..
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process of hypertrophy. Hence the increase in myo­
cardial DNA content implied an increase in the DNA 
content of each myocardial cell. In accordance with 
this, an increase in DNA per cell presumably indicating 
polyploidy in the nuclei of myocardial cells, has been 
reported (Sandrilter et al, 1964, Kompmann et al, 1966).
On the other hand several investigators have measured 
DNA content of individual cells within the hypertrophied 
myocardium and have found that virtually the entire increase 
in DNA content within the myocardium during hypertrophy 
occurs in connective tissue cells rather than in myo­
cardial cells (Meerson 1967, Morkind and Ashford 1968,
Grove et al,1969). These authors consequently concluded 
that there v/as no increase in nuclear DNA synthesis in the 
myocardial cell during hypertrophy, and that each unit of 
DNA in the hypertrophied myocardial cell served a greatly 
expanded cell volume.
The process of transcription is thought to increase 
during myocardial hypertrophy. Actinomycin D specifically 
inhibits RNA polymerase and thereby blocks the DNA depend­
ent synthesis of RNA. Experimental coarctation of the 
aorta following the administration of actinomycin D does 
not cause hypertrophy. Instead, heart failure ensues 
rapidly without activation of protein synthesis (Meerson 
1969, Zuhlke et al, 1966). On the other hand, in the 
absence of experimental stress, administration of 
actinomycin D does not result in an immediate inhibition 
of/.,.
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of protein synthesis, indicating that the already 
synthesised RNA is capable of carrying out protein 
synthesis for some time* Clearly the acutely over­
loaded heart must need increased RNA synthesis.
The stimulation of RNA during hypertrophy seems 
to occur to about the same extent in all species of RNA.
The distribution of labelling the various types of RNA, 
(28s, 18s and 4s) separated by sucrose density gradient 
centrifugation,is the same for hearts of animals with 
aortic constriction as for those of the control animals 
(Kolde et al 1969, Posner et al 1966).
The activation of the process of translation 
during hypertrophy is indicated by an increased incor­
poration of amino acid into protein. Following an acute 
overload, there is an increase in the incorporation of 
amino acids both in the isolated heart (Schreiber et al,
196 8) and in the rabbit with experimental aortic stenosis 
(Gudbjarnason et al, 1964). In addition Meerson (19 69) 
has shown that this increase in amino acid incorporation 
occurs only during the early stages of acute overload.
When heart failure occurred seven months after coarctation
35of the aorta in the rabbit, incorporation of S-methionine 
into mitochondria protein and actomyosin was decreased.
What relation this decrease in amino acid incorporation 
may have to heart failure is unknown. Meerson, however, 
has suggested that it could explain the failure to renew 
cellular structures.
It has been suggested that certain rate-limiting 
steps/..,
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steps in normal myocardial energy metabolism may limit 
the ability of the myocardium to respond to acute stress. 
For instance, during the early stages of experimental 
cardiac overload increased nucleic acid and protein 
synthesis require an increased supply of ribose-5- 
phosphate which is formed from glucose-6-phosphate in 
the pentose phosphate shunt. These reactions are 
catalysed by transketolase and transaldolase and, since 
transketolase activity may be rate-limiting in the'for­
mation of ribose-5-phosphate (Bruns et al, 1958) , myo- 
cardiac requirements for this substrate may not be met. 
Indeed, Meerson (1967) has shown that inhibition of 
transketolase activity with oxythiamine inhibits protein 
synthesis in myocardial hypertrophy produced by severe 
coarctation of the aorta.
Several studies have shown that in the early stages
of hyperfunction there is an increase in the pentose
phosphate shunt (Meerson et al, 1960, 1962). However,
during the late stages of cardiac hypertrophy there was a
decrease in.this pathway (Matsumoto et al, 19 65).
5.4.0 Catecholamines
Recently several studies have demonstrated that
hypertrophied hearts contain abnormally low concentrations
of norepinephrine. Fischer et al, (19 65) found both the
concentration of endogenous norepinephrine and the binding 
3of exogenous H-norepinephrine to be diminished in hyper­
trophied hearts from rats subjected to constriction of the 
abdominal aorta for two months. Other investigators have 
also/. .
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also found diminished norepinephrine stores in hyper­
trophy (Chidsey et al, 1964, de Champlain et al, 1968).
Poole et al, (1967) have attributed the decrease 
in norepinephrine to a deficiency of the enzyme tyrosine 
hydroxylase. Fischer et al, (1965) suggested that there 
may be increased turnover of catecholamines resulting 
from both decreased rebinding of norepinephrine released 
from sympathetic nerve endings and decreased binding of 
circulating norephinephrine. Although de Champlain et 
al, (19 68) demonstrated an increased monamine oxidase 
activity in hypertrophied heart muscle, they concluded 
that this could not account for the decrease in nore­
pinephrine. Regardless of the cause for the depletion 
of norepinephrine, it appears from the studies of Span 
et al, (1966) that it can be associated with normal con­
tractility in the isolated muscle and, hence, that nore­
pinephrine deficiency alone cannot explain an alteration 
in contractility of hypertrophied muscle-
5.5 Energy Utilisation
(1) "Excitation Contraction Coupling" is the 
series of events leading from electrical depolarisation 
of the muscle membrane to contraction of the sarcomere. 
Electrical depolarisation of the muscle membrane is 
carried to the interior of the cell via the transverse 
tubular system (T-system) which then forms a junction 
with the longitudinal series of tubules which surround 
the myofilaments- 
The/...
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The sarcoplasmic reticulum is capable of con­
centrating calcium ion against a large concentration 
gradient and the activity of this calcium pump is 
associated with stoichiometric utilisation of ATP. In 
the resting state, these membranes are able to decrease 
the concentration of calcium ion in the area of the myo-
. . '7
filaments to less than 10 Contraction is initiated
when calcium is released from the sarcoplasmic reticulum 
into the area of the myofilaments, increasing the calcium 
concentration to the level of 10
The nature of the junction between the T-system 
and the sarcoplasmic reticulum and the means by which 
electrical depolarisation of the T-system causes release 
of calcium from the sarcoplasmic reticulum are not 
completely understood, nor is it clear how calcium itself 
initiates contraction. However, knowledge in this area 
has been advanced in the last ten years. It is known 
that tropomyosin plays an important role in the interaction 
of Ca with actin and myosin and that tropomyosin is 
distributed alone the thin filaments of actin. The active 
component of tropomyosin relative to Ca is another 
protein, troponin. In the absence of Ca , troponin 
inhibits the interaction of actin and myosin and prevents 
. muscle contraction. In the presence of Ca this
inhibition is removed, actin and myosin interact and con­
traction occurs.
The possibility that a defect in excitation con­
traction/. . .
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contraction coupling could underlie the hypertrophied 
failing heart has been recently considered. Recent 
studies by Harigaya and Schwartz (19 69) and Siegal et 
al, (19 69) seem to suggest an alteration in calcium 
transport. These authors suggested that an alteration 
in calcium metabolism might be an important factor in the 
hypertrophied failing heart.
5. 6 Contraction
The physiological function of the myocardial cell 
contraction is performed by specialised organelles, the 
myofibrils. The changes that occur may be explained in 
terms of theories of muscle contraction where the develop­
ment of force and power depend on the interaction of
.-j-.
myosin, actin, ATP, Mg and Ca . The sliding filament 
hypothesis describes the interaction of actin and myosin 
by means of cross-bridges which extend from myosin to 
actin. This interaction produces a force of displacement 
by cyclic binding of the myosin cross bridges to actin.
A prerequisite for activity in this model is the
-[- —j- -|—
hydrolysis of ATP in the presence of Mg and Ca by the
contractile protein complex actomyosin. In this context,
the ATPase activity of myosin has been correlated with 
velocity of shortening and tension development(Barany 1967).
. Recent studies by Meerson (1969)on dogs? Alpers and 
Gordon ^ 9 62),tAhuman; Gordon and Brown (l9 6 6^ ,»Ahuman) have 
shown decreased ATPase activity in the failing hypertrophied 
heart. However, studies by Chandler et al (196 7) ,/r^ cat? 
Olson/...
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Olson, (1961), in dogs, revealed no change in ATPase 
activity. This mechanical-biochemical discrepancy may 
result from differences in the cationic milieu in which 
the protein ATPase activity is assayed. This area 
obviously needs more investigation.
6.0 Pathogenesis of Cardiac Hypertrophy
Many theories have been proposed to explain the 
development of cardiac hypertrophy (Willius et al 19 34, 
Merrmann et al 1939).
6.1 The Theory of Work Hypertrophy attributes cardiac 
hypertrophy to an increase in the work of the heart. The 
size of an animal's heart increases in proportion to the 
amount of activity necessitated by its mode of life and 
cardiac hypertrophy can be induced by exercising dogs 
(Steinhaus 1933). Clinical and pathological observations 
disclose that hypertrophy of a chamber occurs when its work 
is increased in compensation for a valvular or circulatory 
abnormality. A modification of this theory regards a 
chronic increase in myocardial metabolic rate per beat 
(oxygen consumption per beat) as a stimulus to cardiac 
hypertrophy (Badeer, 1964) .
6.2 The Nutritional or Hypoxic Theory attributed cardiac 
hypertrophy to a defective blood supply. Hypertrophy has 
been demonstrated repeatedly in clinical and experimental 
anaemia and in experimental coronary ligation (Normal et al, 
1960). The cardiac hypertrophy in arteriovenous aneurysm 
and aortic insufficiency is thought to be due to a deficient 
coronary circulation/.,.
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circulation (Lewis et al, 192 3). Cardiac hypertrophy 
can be introduced in rats either by exercise (work 
hypertrophy) or by prolonged intermittent exposure to 
low tension. The essential difference is the
relatively greater hypertrophy of the right ventricle in 
the latter group, presumably due to increased pulmonary 
vascular resistance secondary to hypoxia (Van Liere et al, 
1965).
6.3 The Injury Theory suggests that cardiac hypertrophy 
is a reaction to tissue injury which acts as a "pathologic 
nutritive" (Albrecht et al, 1903, Eyster et al, 1927).
Its validity has been questioned in a critical appraisal 
by Kerr (1957),
6.4 The Muscular Stretch Theory suggests that the 
fundamental cause of hypertrophy is the stretching of 
muscle fibers (Horvath 1897)* This is not necessarily 
contradictory to the other theories, but rather an attempt 
to define, more clearly and precisely, their application. 
Stretching of myocardial fibers results whenever this 
diastolic volume and pressure are increased by enhanced 
inflow, impaired myocardial contraction or increased re­
sistance to outflow. This is the stage of cardiac 
dilatation. Increased fiber length may alter both the 
shape and size of the heart, factors which influence the 
degree of myocardial tension and oxygen requirement (Burton 
et al, 1957).
Ultimately increased oxygen utilisation appears 
important/,,,
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important to the growth process which underlie hypertrophy. 
It has been suggested that the tension-time index, which 
is a measure of increased myocardial work, and often the 
oxygen requirement may serve as the "indicator" to the 
deoxyribonucleic acid (DNA) genetic coding centre in the 
myocardial to order a controlled synthesis of ribonucleic 
acid (RNA) and protein for required growth of hypertrophy 
(Norman, 1962)* The tension-time index can be correlated 
with dilatation which by itself, or in association with 
increased heart rate, may be the stimulus to cardiac 
hypertrophyo
The lengthening of muscle fibers results in greater 
surface area for an unchanged mass of muscle. This 
permits a relatively greater nutritive diffusion surface 
between blood and fiber and, therefore, leads to the 
fiber’s growth* In due time the dilated fibers become 
hypertrophied. This may explain the development of 
cardiac hypertrophy following dilatation in cases of 
valvular and vascular lesions as well as in instances of 
myocardial disease* Hormonal factors especially thyroxine 
and growth hormone may be concerned in the development of 
cardiac hypertrophy (Beznak 1960, 1964) .
Progressive heart failure is a potent factor in 
pronounced cardiac hypertrophy because it is responsible 
for progressive increase in diastolic volume and consequent 
muscle stretch. On the other hand, increased work of the 
heart does not appear to cause hypertrophy if the addition­
al work/...
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work is due exclusively to tachycardia while the stroke 
output is not enhanced, as in most cases of uncomplicated 
hyperthyroidism. Finally, there may be many unknown 
extrinsic or intrinsic factors controlling the metabolism 
of the muscle fiber which may account for marked 
differences in the degree of hypertrophy experienced by 
different hearts in response to apparently similar 
'pathologic" disturbances * Hearts in aortic stenosis 
have varied from virtually normal weight to over 2000g 
(Lowe et al 194 8) - sometimes without any correlation 
with the degree of stenosis or duration of illness* 
Although marked hypertrophy is the rule in cases of 
hypertension with heart failure, little or no hypertrophy 
has been found at autopsy in the hearts of some patients 
with these conditions (Kleinfeld et al, 19 52).
“2 8“
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At the beginning of the present investigation, 
the situation could be summarised as follows. Histo­
logical and morphological studies had generally showed 
that the hypertrophic heart was not merely larger than 
usual? it also contained much more fibrous tissue than 
the normal heart and the fine structure of the myocardial 
cells was abnormal in a number of important respects.
One might expect that the morphological changes
and more especially the loss of efficiency should have a
biochemical aspect and might even to the ultimate be
capable of explanation in purely biochemical terms.
However, minimum biochemical changes have been reported
"4" “f"in abundance? Ca transport is marginally depressed; 
the concentration of ATP and phosphocreatine are marginally 
depressed? in spite of the increased functional demand, 
uptake and, to a greater degree, oxidation of fatty acids 
is depressed? the glycogen reserve of the myocardial cells 
is depressëdfwhile the lactate content is increased.
Neither individually nor in combination do these changes 
indicate damage to the myocardium; but they do suggest 
that it is being pushed beyond its normal physiological 
limit and is perhaps not coping very successfully with 
the challenge. There seemed a need for a more detailed 
investigation on these lines.
CHAPTER II RESULTS
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SECTION I RESULTS
1,'G Introduction
In their attempts to understand the metabolic 
abnormalities during myocardial hypertrophy and heart 
failure, most investigators have directed their atten­
tion to the mitochondria and oxidative metabolism as 
the major source of energy production in the heart* 
However, an additional factor which must be considered 
in the bioenergetics of the hypertrophied myocardium 
is the increased demand placed upon the energy resources 
of the heart by alterations in hemodynamic and mechanical 
factors. When oxidative metabolism is taxed to its 
limit, or if inhibitory factors are operating, it is 
reasonable to assume that, reserve sources of energy 
production will be brought into action. The role of 
glycolysis in meeting this increased energy demand has 
received little attention. It has also been argued 
that a decrease in the ratio of capillary to myofibril 
during cardiac hypertrophy leads to hypoxia in the myo­
cardium (page 5 ) as a result of the increase in the 
diffusion distance from the capillary lumen to the centre 
of the hypertrophied area. Since direct methods of 
determining the intracellular distribution of oxygen are 
not available, indirect means were sought.
The association of different isoenzymes of lactate 
dehydrogenase (LDH) with aerobic and anaerobic metabolism 
(Chan et al, 196 2, Markert, 196 3, Dawson et al, 1964) and 
the shift in the isoenzymes distribution, which occurs 
with/...
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with altered environmental oxygen availability,
(Johansson, 196 6, Lindy and Rajasalmi, 19 66, Thorling 
and Jensen, 19 66) appeared to afford a means of evalua­
tion myocardial oxygen availability*
Lactate dehydrogenase exists as a tetramer made 
up of two types of genetically determined subunits - 
heart (or H.) and muscle (or M) corresponding to their 
respective preponderance in these tissues (Appella and 
Markert, 1961).
The nomenclature used in this study to describe 
the various isoenzymes of lactate dehydrogenase will be as 
follows: LDH I, LDH II, LDH III, LDH IV, and LDH V,
LDH I carrying the highest negative change and migrating 
furthest towards the anode during electrophoresis.
The theory that the pattern of LDH isoenzymes in 
a tissue is associated with the metabolic activity of 
that tissue is based mainly on the observation that tissues 
highly dependent on aerobic metabolism,such as heart and 
brain, have a predominance of H subunits (Vessell et al, 
1962, Dawson et al, 1964), whereas, tissues such as white 
skeletal muscle and uterine smooth muscle which function 
well under anaerobic conditions have a predominance of M 
subunits (Vessell et al, 1962, Dawson et al, 1964),
Exposure of heart cells (originally derived from 
primary explant of monkey heart) in tissue culture to low 
oxygen tensions provokes an increased synthesis of the 
LDH V isoenzyme (Goodfried et al, 1966) , These findings 
indicate that cells are capable of adapting their LDH 
isoenzymes/...
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isoenzymes in response to environmental variation in 
oxygen availability.
Recently, Bello and Messer, (19 6 8) measured the 
percentage of M chains present in cardiac LDH for patients 
who had a combination of diminished tissue perfusion and 
cardiac enlargement as evidenced by coronary artery narrow- 
ine and increased heart weight (greater than 325g for 
females and 375g for males), They found that hearts which 
were enlarged and poorly perfused had a greater proportion 
of M chains of LDH as compared to hearts with or without 
coronary artery disease and/or mild cardiac enlargement.
They concluded that these changes in the proportion of 
M chains of LDH were related to an enhanced utilisation of 
anaerobic glycolysis in association with cardiac hyper­
trophy.
The idea that the hypertrophied myocardium is bio­
chemically similar to embryonic myocardium is quite 
attractive. Embryonic and young growing myocardial 
tissue, which is less susceptible to the effects of hypoxia 
than adult myocardium, contains greater amounts of M-LDH 
(Dawson et al, 1964). The finding by Bishop and Altchuld 
(1970) of increased rates of lactate production and glucose 
uptake by anaerobically incubated homogenates of hyper­
trophied ventricles is additional evidence that hyper­
trophied myocardium utilises anaerobic glycolytic metabolism 
to a greater degree than normal myocardium.
Further studies, it was felt, were necessary to 
determine whether changes in the M chains of LDH were 
associated/.,,
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associated with cardiac hypertrophy or related to a
.marked decrease in tissue perfusion (i.e. hypoxia)-
If changes in the M subunits were a result of 
cardiac hypertrophy then marked enlargement should 
result in the greatest change in M-LDH* However, if 
the changes in M-LDH were related to tissue perfusion 
then these hearts in which perfusion was most impaired 
should show the greatest change in M-LDH.
1.1 Clinical and Morphological Data
Subjects were selected (Table 1) by the attending 
pathologist, based on the following criteria? the controls, 
group A, were patients who had died accidentally or by 
violence. The heart weight in this group averaged 340g 
for males and 300g for females and coronary arteries were 
normal ? patients in group B all showed marked coronary 
narrowing with moderate cardiac enlargement (i.e. 50% over 
the control); the patients in group C had marked cardiac 
enlargement (i.e. 100% increase over the control) with or 
without moderate coronary artery disease.
Additional evidence substantiating cardiac hyper­
trophy was provided by left and right ventricular wall 
thickness (Table 1). The left and right ventricular walls 
in group B were increased by 40% and 29%, respectively, 
while the left and right ventricular wall of group C were 
increased by 87% and 50% respectively.
1.2 Lactate Dehydrogenase Isoenzymes
Sections of the left ventricular free wall were 
removed at autopsy within 7 to 2 4 hours of death. Samples 
of/,.,
TABLE 1
CliAical and î.îorohologica,! charac/berization of j)atient arouns*
Group the control? neither coronary artery disease nor cardiac 
enlargement* Group II marked, coronary artery disease with moderate 
cardiac enlargement * Group III marked cardiac hypertro%Ay with or 
without coronary artery dj-sease*
a
Number of Cases 
Male/Female 
Heart Weight (g)
Left ventricular wall 
thickness (cm)
Right ventricular wall 
thickness (cm)
19
15/4
320 +40
1c5 +0.05
14 
12/2  
477 ±50
12 
10/2 
669 ±80
2.1 ±0.10 2.G ±0c07
% ###
0.14 ±0o01 0*18 ±0*03 0.21 ±0.04
•}f ->Hf
Mean + SlXî %p<0.05, #Kp/i0o01; 0.001
Fig* 1 The percentage of lactate
dehydrogenase isoenzymes in 
normal heart, liver and 
skeletal muscle from human 
at autopsy. Also present 
in Fig,, 1 are the percentage 
of lactate dehydrogenase 
isoenzymes from Helu cells 
of the fourth passage.
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of normal liver and skeletal muscle were removed to 
check whether (the slower moving) heaf sensitive iso­
enzymes LDH IVf V were retained„ These samples were 
homogenised and the homogenate were centrifuged at 
20f000xg for 20 minutes„ The supernatants were then 
subjected to electrophoresis on polyacrylamide gels.
The results from these experiments are sliown in 
Tables 2 - 3 - 4 .  The typical LDH isoenzymes dis­
tribution in normal human heartliver and skeletal 
muscle is shown in Fig. 1.
Relative to the control group group B showed 
a decrease in isoenzyme I^  while isoenzymes 111, IV and 
V were significantly increased. Group C showed a modest 
decrease in isoenzyme I and an insignificant increase in 
isoenzymes III, IV and V (Table 2).
The relative amounts of heart and muscle subunits 
were calculated from the percentage of isoenzymes (Appella 
and Markert 1961, Cahn et al, 1962). The M subunits in 
group B were significantly increased by 60%, while group 
C showed a significant increase of 31% over the control 
(Table 3) .
As would be expected, liver and skeletal muscle 
showed a predominance of isoenzymes III, IV and V and of 
M subunits of LDH (Plummer et al, 1963^ Vessell and 
Bearn, 19 61). These slow moving heaf sensitive iso­
enzymes did not show much variation during the experimental 
period (Table and b) «
To corroborate these changes in the isoenzymes and 
subunits/...
TABLE 2
The percentage of lactate dehydrogenase isoenzymes in the left
ventricular free wall from various patients groups*
1J3H Isoenzyme8
Group ]lo. of patients
I II III IV 7
A 19 49 36 12 2 1
4'1 o1 ±0^4 ±0*030 ±0*004
B 14 31 38 21 6 4
4:2.3 ±1 *3 ±0*6 ±0*050 ±0*005
C 12 28 40 16 4 2
42*0 ±1*9 ±0*6 ±0*038 ±0*005
TABLE 3
The percentage of M subimits in the left ventricular wall from 
various patient groups.
M suhmiits of LDH
A 19 17*5
4-1 *16
B 14 28*5
"t1 *64
C 12 23,0 -X"
+1.19
Mean + Sai »p<0.05, » p <0.001
The percentage of lactate dehydrogenase isoenzymes and M subunits 
in normal liver and skeletal muscle *
LDH isoenzymes
Tissue
Liver
ITo * of 
patients
10
40*8
II
16 
4I o4
III 17
24
7
27
4I.6 4106 42*4
Skeletal
muscle 13
41.3
10
±0»9
30 27 18
42 p 3 42 « 1 4I c 5
Mean 4 8EM
U subunits of L M
Tissue No* of 
patients
%
Liver 60*5
42*31
Skeletal 
liras cl e 55.5
42*08
Mean -1- SIM
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subunits of LDH, high and low concentrations of pyruvate 
were used as a measure of the percentage of H and M - 
LDH present in the left ventricular free wall from the 
various patient groups.
1,3 Pyruvate Inhibition
Dawson et al. (19 64) have shown that relatively 
high concentrations of pyruvate inhibit the H subunits 
of LDH,. Gntfreund et al, (196 8) have suggested that 
this inhibition is related to the formation of an abortive 
ternary complex between NAD , pyruvate and LDH,
Kaplan et al, (1960) have advanced the hypothesis 
that inhibition of LDH by high tissue concentrations of 
pyruvate may assure a constant flow of pyruvate into 
pathways of oxidative phosphorylation. They observed 
that tissues, such as the heart, which rely on oxidative 
phosphorylation contain predominantly LDH I (which is 
inhibited by pyruvate) while tissues, such as skeletal 
muscle, relying partly on anaerobic glycolysis, have a 
predominance of LDH V (which is pyruvate independent) , 
However, the validity of this hypothesis has been 
questioned by Vessell and Pool (1966) and Stambaugh and 
Post (1966), on the grounds that the temperatures and 
pyruvate concentrations employed were outside the physio­
logical ranges. Although inhibition in vivo of LDH has 
been questioned, studies in vitro have established that the 
amount of substrate inhibition is directly proportional to 
the percentage of H chains in the enzyme (Plagemann et al, 
1960).
In/..,
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In the present study the relative proportions
of* H subunits of LDH were estimated by using high
.^A -3
(xlO M) and low (xlO M) pyruvate concentrations *
Tables 5 - 6  show the results of such estimations on
supernatants from heart, liver and skeletal muscle.
The control or group A showed a 59% inhibition 
at high pyruvate concentration while Bello and Messer 
(1968) found a 70% inhibition at the same concentration. 
However, a higher proportion of M subunits were found in 
the control group in the present study than in the control 
results of Bello and Messer* Group B showed 44% in- • 
hibition which was significantly less than the controls.
A 52% inhibition was found with group C* This was not 
significantly different from the controls* In other 
terms, group B showed an increase in LDH activity (or 
less inhibition) at high pyruvate concentration of 37%, 
while group C showed an increase of 17%* Bellow and 
Messer found an increase of 33% in patients similar to 
group B in this experiment.
To sum up: hearts which were moderately hyper­
trophied and poorly perfused showed a marked increase in 
M subunits of LDH as evidenced both by electrophoresis,
. . and by pyruvate inhibition; while hearts which were 
markedly hypertrophied and moderately perfused showed no 
significant change.
These results tend to support Bellow and Messer's 
view that severe hypoxia and mild cardiac enlargement 
result in a shift to a greater proportion of M subunits. 
This/,.,
TABLE
Lactate dehydrogenase enzyme activity at different concentration 
of pyruvate in the left ventricular free wall of vairious patient groups,
Groups No® of patients
A 19
B 14
12
Lactate dehydrogenase activity in the presence
of;
Low pyruvate oonr- High pyruvate corr*
x10"3 M %10~4 II
moles / mill / g v/et weight 
216 88
±22 8
195 110
i16 H^11
201 96
±19 ± 7
Mean + SEîrl
TABLE 6
Lactate dehydrogenase enzyme activity at different concentration 
of pyruvate in normal liver skeletal muscle®
Lactate dehydrogenase activity
Tissue No. of patients 
Liver
Skeletal
Muscle
Low pyruvate coir- 
xIO*"^  M
High pyruvate corr- 
x10~4 M
moles / mill / g wet weight
168 ■ 240
±12
219
4-19
±17
315
4-26
Mean -i- SjÜ
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This shift during severe hypoxia might reflect an 
altered control of LDH synthesis during cardiac enlarge­
ment? on the other hand, marked enlargement with mild 
hypoxia did not produce this*
An alternative explanation might be that the 
changes in isoenzymes represent a change in the relative 
proportions of different cell types in the heart* The 
attending pathologist observed that group B, which 
exhibited the greatest change in M subunits also exhibited 
cardiac fibrosis with recent or old infarctions. Hearts 
in group exhibited only small areas of cardiac fibrosis 
and group A (the ^ controls) exhibited none. He concluded 
that connective tissue in groups B represented an 
appreciable amount of the left ventricular free wall as 
compared to group C or the control group A. Fibrosis 
Involves the proliferation of fibroblasts and the sub­
sequent synthesis of collagen which is laid down in areas 
which have previously undergone necrosis. Accordingly 
attempts were made to determine whether there was a 
relationship between fibrosis and the proportion of M 
subunits in the heart.
1.4 Hydroxyprollne
 ................lT»ll L m u ® l"l ■ 11» ■ * I
Hydroxyprollne is found exclusively in collagen, 
in which it forms a constant percentage of 13,4% by weight 
(Neuman and Logan 1950). The concentration of collagen 
and thus the connective tissue component of the myo­
cardium can, therefore, be estimated by determination of 
hydroxyprollne.
The/...
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The evidence on the abundance of connective tissue 
in* human hypertrophic hearts is conflicting. Oken and 
Eoucek (1957) showed that the collagen concentration in 
20 out of 22 human hearts with significant left ventricular 
hypertrophy v/as normal. Similar studies by Monfort and 
Perez-Tamoyo (1962) who measured the ratio of collagen to 
muscle protein in the hypertrophied human left ventricle 
showed no change in the collagen content. On the other 
hand, Blumgart et al, (1940) found increases in the 
collagen concentration in 9 out of 24 hypertrophied human 
hearts® Vail (1939) and Krymski (1962) both observed 
increased areas of fibrosis in the human hypertrophied 
heart.
These conflicting results might be in part explained 
by the method used to excise the left ventricle. Montfort 
and Perez- Tamayo (1962) cut away the endocardial and 
epicardial layer before estimating hydroxyprollne. However, 
Vail (1939) and Krymski (1962) both noticed it was pre­
cisely in these layers that the increase in fibrous tissue 
was located. Unfortunately, these investigators did not 
measure the amount of collagen chemically.
In the present study, sections of left ventricle 
removed at autopsy were homogenised, as in estimation of 
LDH isoenzymes, without cutting away the endocardial or 
epicardial layers. The results of hydroxyprollne 
estimations are shown in Table 7, In comparison with 
group A(_the controls^ group B showed a significant increase 
in hydroxyproline, while group C showed a smaller but still 
significant/,,.
TABLE %
The hydroxyproline concentration in the left ventricular free 
wall from various patient groups.
Groups No® of T)atientB Hydroxyproline 
nig/g dry weight
A 19 2,24 
j+O 0 34
B 14 4.36 * *  
40*71
c 12 2.98 '% 
+0.39
Mean + S34 0*09, 0*001
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significant increase.
These chemical findings appeared to warrant
histological comparison*
1. 5
Histological Studies
Histological sections were taken from three parts 
of the left ventricular free wall, the anterior, posterior 
and lateral*
Determination of the relative amounts of fibrous 
tissue, myocardial cells and other cellular elements, was 
achieved with a microscope fitted with a grid in one of 
the eyepieces, A total of 25 fields was examined in 
each section and in each field the number of grid inter­
sections that fell upon myocardial cells, fibroblasts or 
collagen and other cells (i.e. endothelial cells and 
histocytes) was recorded. These observations were made 
in areas which were not highly vascularised (i.e. not 
heavily endowed with arteries or capillaries) . Figs, 20s~ 
b - Cbshow typical sections from groups A, B and C.
In group A (the controls) the lateral section of 
the left ventricular free wall appeared to contain a 
relatively higher proportion of muscle cells than fibrous 
tissue; the anterior and posterior showed a greater 
amount of fibrous tissue and the muscle cells were 
correspondingly reduced (Table 8 - 9). However, there 
was no significant difference between these results.
The results from group B showed that, compared 
to the controls, myocardial cells decreased, while 
fibrous tissue and other cellular elements significantly 
increased in all three. Group C showed a small decrease 
in/...
Pigo 2-a«b"C Sections of the left ventricular free wall from
human at autopsy stained for collagen with Masson* s 
stain which appeans green, counterstained with 
Hamalum»
Piho 2a Marked left ventricular hypertrophy (Group C)
without coronary artery disease with 
diffuse collagen. (Mag x 290).
Pih, 2b Moderate left ventricular hypertrophy with
marked coronary disease (Group b) with 
marked increase in collagen* (Mag x 100),
Pib. 2c . Normal left ventricle (Group A) with
sparse collagen. (Mag x 250).
f
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Histological counting in the anterior, lateral and posterior sections 
of the left ventricular free wall from the various patients groups * The 
value expressed below represent the number of times the grid intersection 
fell apond (m ) or muscle cells, (]?■) or fibroblast and collagen end (O) 
or other cells (ioe® histocytes and endothelial cells)*
Anterior Lateral Posterior
Groups No e of patient M ¥ 0 M ¥ 0 M ¥ 0
A 10 1311 271 119 1344 272 108 1300 289 111
+68 +16 +12 ±73 +20 ±13 ±56 +23 +12
B 8 1060 460 180 1050 470 100 1064 440 195
+60 +17 +20 +40 +24 ±■14 ±43 +18 +21
C 10 1210 360 130 1320 285 95 1220 380 100
+85 +18 +13 ±57 +21 +16 ±74 ±15 +14
Mean + SE^ î
TABLE 9
The percentage of M or muscle cells, E or fibroblast and collagen and 
0 or other cells (i.e. histocytes and endothelial cells) in the anterior, 
lateral and posterior from the various patient groups.
Anterior Lateral Posterior
M ¥ 0 M F 0 M F C
Groups No® of patient fo
A 10 77 16 7 79 14 7 76 17 7
B 8 62 27 11 62 28 10 63 26 11
C 10 71 21 8 78 16 6 72 22 6
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in muscle mass in the anterior and posterior sections, 
while the lateral section was unchanged. Fibrous tissue, 
and other cellular elements in group C was either 
unchanged or slightly increased.
The chemical and histological studies both indicate 
that fibrous tissue and other cellular elements had con­
siderably increased in group B, Although group C showed 
similar changes they were very much smaller.
1. 6 Attempted Isolation of f*]ascle dells
It seemed advantageous, therefore, to separate the 
various cellular elements in the left ventricular free wall 
and determine their characteristic patterns of LDH iso­
enzymes, It was thought that this experiment would answer 
the question whether the new tissue which is added as a 
result of cardiac hypertrophy has an altered pattern of LDH 
isoenzyme. Using a modification of the method of Berry et 
al, (1970) a section of the left ventricular free wall was 
cut into small 1mm cubes and incubated for one hour in a 
buffered solutation of collagenase and hyaluronidase. These 
enzymes should digest the connective tissue (i.e. collagen 
and ground substance), and release free cells. The different 
cell types should then be separable on the basis of size and 
density by sedimentation through a serum gradient under 
gravity. This experiment was unsuccessful since complete 
digestion was never achieved. Incubation for as long as 4 
hours with various concentrations of collagenase and hyal­
uronidase did not lead to an appreciable release of the 
individual cells.
Because of this an alternative experiment was 
designed/,..
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designed which involved harvesting Helu cells (human 
embryonic lung cells) which have been replaced by 
predominantly fibroblast and determining the percentage 
of M-LDH.
1.7 Helu cells of the fourth passage were used to
determine the M-LDH content. Fig* 1 shows the typical 
distribution of the LDH isoenzymes found in the Helu cells. 
The results from these experiments show that Helu cells 
contain a predominance of the (slower moving) isoenzymes 
III, IV and V, The predominance of M subunits of LDH was 
further demonstrated by a pyruvate inhibition experiment 
(Table 10).
These results clearly demonstrate that fibroblast 
or Helu cells contain a predominance of M-LDH, Since 
fibrous tissue was found in appreciable amounts in group B, 
they do help to offer an alternative explanation to the 
changes found in M-LDH in groups B and C.
TAm^_10,
' The percentage of lactate dehydrogenase isoenzymes and high-low 
pyrpyate kinetics in Helu cells *
No» of Experiments
5
+0*8
Lactate dehydrogenase isoenzymes
II III IV V
io
22 36 29 7
_+1 o 6 o 1 +1 o 8 +0 * 6
Mean + SM.
No® of Experiments
Low pyruvate con— 
"3
Lactate dehydrogenase activity in the presence
of s
High pyruvate con^ 
x 1 0 M  x10"4 II
moles / min / g wet weight
290 365
+24 +39
Mean + 83','I
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1.8
Myocardial Enzymes
The reported changes in the structure of the mito­
chondria (Wollenberger, 196 3) and anaerobic glycolysis 
(Bello and Messer, 19 68) associated with congestive heart 
failure and enlargement, seemed to warrant a study of 
cardiac enzyme activities, especially since a change in 
metabolism might be responsible for the failing heart.
The enzymes abhosen were selected as representative 
of three metabolic pathways: the Embden-Meyerhof pathway
(lactate dehydrogenase (LDH))? the citric acid cycle 
(malate dehydrogenase (MDH)and NADB^dependent isocitrate 
dehydrogenase (ICDH)); and the pentose phosphate pathway 
(glucose-6-phosphate dehydrogenase (C-6-PDH)), The 
activities of creatine phosphokinase (CPK) and glutamic- 
oxaloacetic transaminase (GOT) were also measured.
The enzyme pattern from patients in group B with 
poorly perfused tissue or marked cardiac enlargement (group 
C) in general differed from the control group A (Table 11). 
The activity of ICDH in hearts from group B showed a 
significant decrease to 44% of control activity while ICDH
in group C was decreased by 75% of the control activity.
The activities of MDH and LDH were insignificantly decreased 
in both groups. Finally, G-6-PDH, CPK and GOT were slightly 
but insignificantly decreased in group B, while these enzymes 
in group C were the same as the control or slightly elevated.
It appears from the results of M-LDH and the intra­
cellular enzyme activities that group B or those hearts which 
were moderately hypertrophied and poorly perfused showed the 
greatest/...
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greatest change as compared to hearts which showed a 
marked increase in weight, with or without moderate 
coronary artery disease.
However, it was difficult to conclude from these 
results whether the changes observed in M-LDH were 
associated with increases in histocytes, endothelial cells 
and fibroblasts or related to the myocardial cell, although 
it would appear that fibroblasts were related to the changes 
in M-LDH. The changes in the six intra-cellular enzymes 
activities during the above study might also be explained 
by decrease in the mass of sarcoplasm due to necrosis and 
subsequent fibrosis and/or an increase in the autolytic 
process due to an increase in histocytes and fibroblast 
which contain high levels of hydrolytic enzymes. This 
problem could only be circumvented by parallel studies in 
experimental animals.
“ 4 3‘”
SECTION II
2,0 Introduction * The events described in the previous 
section demonstrated that some of the chemical findings 
attributed to cardiac hypertrophy are in fact due to the 
concomitant fibrosis. It was clearly of interest to see 
whether these findings in autopsy material, could be 
repeated and extended in experimental animals*
Cardiac hypertrophy in animals can be induced in a 
variety of ways, as is shown in Table 12., For our purpose 
it was clearly desirable to find a method which would induce 
hypertrophy in a reasonably short period. It was also 
desirable to select a method which varied the extent of 
fibrosis. On these principles three methods were chosen -
1. Coarctation of the aorta.
2. Injection of thyroxine.
3. Injection of isoprenaline.
The effects of these methods in producing enlarge­
ment are discussed below.
Coarctation of the abdominal aorta induce^ cardiac 
enlargement as a result of increased peripheral resistance, 
which in a way, may be similar to hypertension. This means 
that the heart has to pump out a normal amount of blood 
against an abnormally high resistance. The resulting hyper­
trophy varies depending on the length of time, and the degree 
of constriction. When the abdominal aorta is constricted to 
approximately 60% of its original diameter, marked cardiac 
enlargement can usually be produced within periods of less 
than 30 days (Meerson, 1969), This is usually accompanied 
by/...
TABLE 12
Methods of inducing cardiac hypertrophy in animals,
Methods employed to 
indue e hy^ertro oh y Suecies
Degree of 
Pïyi'ertroji
Period of 
time
1 * Aortic constriction Dogs j Babbits, 
Hats
25 - 400/ 5 days to 
2 months.
2* Experimental Hypertension
a) DOGA administration Bats
b) constriction of 
renal artery Rats
56/
34/
28 days
30 days
3c High Altitude Hypoxia Rats $0/ 12 days
4® Anaemia Rats W o 3 months
5* Thyroxine injections Rabbits 7S5» 15 days
60 Physical Exercise Rats 35/ 8 weeks
7. Aortic Valve 
In suffi ciency Rabbits 43/ 4 weeks
8, Isoprenaline injections Rats 60^ 0 15 days
9. Coronary Artery 
Ligation Rats 34/ 6 weeks
""4 4”'
by a moderate degree of fibrosis (Bartosova et al, 1969), 
Injection of thyroxine generally increases the 
oxygen utilization in the tissues and subsequently increases 
the volume load to the heart* Cardiac enlargement is the 
result of increased work due to increased heart rate and 
cardiac output (Beznak 1962)* Cardiac hypertrophy appears 
to be variable depending on the dosage, the animals used 
and the period of administration* Generally it is in the 
range of 50 to 80%*
Fibrosis does not seem to accompany the hypertrophy 
(Bartosova et al, 19 6 7) although in the rat Sandler and 
Wilson (1959) occasionally observed small areas of necrosis 
in the apex of the ventricles*
Isoprenaline is a catecholamine similar to adrenaline 
When injected it stimulates the heart rate, increases the 
oxygen requirement of the myocardium and at the same time 
reduces the systemic blood pressure and coronary flow 
(Beznak and Hacker 1963? Denison et al 19 56)* The stim­
ulation of heart rate with the subsequent increase in cardiac 
output may in part be responsible for the resulting hyper­
trophy. However, since isoprenaline injection induces 
marked fibrosis, (Judd and Wexler 1969), the resulting 
hypertrophy may be a result of injury as previously discussed 
(page25 ), However^ that may be, the resulting hypertrophy- 
is substantial and rapid (Rakusan et al, 1965).
RESULTS
2*1.0 Heart and Body Weight
Tables 13a - b show the changes in heart and body 
weight/...
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weight following each of the three treatments. Neither 
saline injection (Table 13a) nor sham operation (Table 
13a) appeared significantly to effect either heart weight 
or body weight. Coarctation (Table 13b) produced a 
marked increase in heart weight without effecting body 
weight. The observed increases were 32% at 10 days and 
89% at 21 days of constriction. Similar results have 
been reported by Meerson (1969).
Thyroxine produced a progressive fall in body 
weight. This was accompanied by a progressive increase 
in heart weight so that the ratio of the latter to the 
former increased by almost 80% (Table 13b). This is in 
agreement with Inchiosa and Freedberg's (1963) previous 
observations„
Isoprenaline, in contrast to the other two 
treatments, produced a 60% increase in heart weight within 
5 days and no further increase thereafter. It had no 
apparent effect on body weight. Similar results had been 
reported by Judd and Wexler (19 69).
2,1.1 •Liver and Kidney Weight
Tables 14a - b show the effects of the same 
treatments on the weights of liver and kidney expressed as 
a ratio to body weight. Saline injections (Table 14a) 
and sham operation (Table 14a) had no discernible effect. 
Coarctation had little, if any,effect/on liver^but kidney 
weight was increased by 25% at 10 days after the operation 
and it was still at this level at 21 days.
Thyroxine had no effect on either liver or kidney 
weight/,.,
TABLE 13ao
The heart and body weights of sham operated and saline controls 
cadiforniaii rabbits at various time intervals®
Saline controls
Ratio of
Days No. of Body weights Heart wet Heart weight/
animals Initial Final weights body v/eidit
(g) (g) (g)
5 9 2,780 2,950 5.7 0.19
±38 ±48 ±0.87 ±0.013
10 7 2,640 2,890 5.6 0.19
+29 +46 +0.66 +0.014
15 23 2,700 3,010 5.8 0,19
+39 +54 ±0.78 +0.016
Bharn operated
6 2 2,680 2,798 5.5 O.19
±30 +26 +0.34 +0.011
10 3 2,600 2,840 5.6 0.19
+29 +40 +0.79 ±0.017
21 7 2,740 3,100 5.8 0.19
±21 ±48 ±0*51 ±0*01b
tie an + S M
TABLE 131-u
- The effects of coarctation, isoprena3.1ne and thyroxine on *r3ody 
and Heart weight in Californian rabbits at various time intervals.
Treatment Days HOo of 
animals
Body wei/'ht 
Initial Pinal
Heart Wet 
Weight
(g) (g) (s)
Controls 49 2690 2958 5.7
+31 +47 +0.72
Ratio of
Heart weight/ 
body weight
0.19
+0.015
Coarctation 10
21 11
2560 2740 6o7 0.25 %-
+40 +35 +0*70 +0.018
2589 2789 9.9 0,36
+32 +47 +0.95 +0.029
Thyroxine 10
10
15 16
2577 2489 5.3 0.21
+38 +31 +0.68 +0.011
2701 2535 6.7 0.26 -*
+27 +58 +0.81 +0.026
2519 2265 7.8 0.34
+32 +41 +0.48 +0.020
Isoprenaline 5 8 2689 2837 8.5 0.30 '%-*
+37 +50 +0,68 ±0.010
10 9 2400 2688 8.2 0,30 X-*
+29 ±44 ±0.83 +0.021
15 19 2654 2950 8.9 0.31 +-%
+39 +59 +0.99 ±0,031
Mean + 8:14, Body and Ileart weight is givin in (g),
#P<0.01, 0.001
TABLE 14&,
The ratio of liver and kidney wot weights to body weight in the 
saline controls and sham operated rabbits at various time Ijrbervals.
Saline Controls
No 0 of
animals
Ratio of 
Liver wei.ght/ 
body weight
Ratio of 
Kidney weight/ 
body weight
3.9
+0.55
0.63
40.059
10 3o9 
+0.73
0.64
+0.048
15 23 4.0
+0*47
0.6l
+0.030
Sham Operated
10 4.0
-0.66
0,64
+0.044
21 4.0
+0.49
0*64
kO.D53
Mean + S3.1
TABLE 14bc
- The influence of coarctation, isoprenaline and thyroxine on the 
ratio o.f liver and kidney wet weight to body weight in Californian 
rabbits at various time intervals*
Treatment
Controls
Ho* of 
animals
49
Ratio of 
Liver weight/ 
body weight
4«o
-1-0 069
Ratio of 
Kidney weight/ 
body weight
0,63
+0.076
Coarctation 10
21 11
3.9
+O06O
4.5
+0*79
0.77 '*
+0*081
0*76
+0.093
Thyroxine 10
10
15 16
4.7
+0*77
3.9
+0.81
3.2
+0.50
0.64
+0.031
0.67
+0*073
0.62
+0.038
Isoprenaline 5
10
15 19
3.2
+0.93
3o7 
+0*94 
5.0 * 
+0*81
0,70
+0.033
0.76 +
+0.041
0.74
+0.084
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weighty but isoprenaline^ like coarctation produced a 
25%‘increase in kidney weight. This, like the increase 
in heart weight produced by the same drug is not pro­
gressive. It was fully developed at 5 days. Iso­
prenaline also appeared to produce a 25% increase in. liver 
weight but this effect is only apparent after 15 days.
It is quite clear therefore that though all these 
treatments produce a satisfactory degree of cardiac hyper­
trophy, they differ widely in their side effects on other 
organs.
2.1.2 Left Ventricular Weight
Tables 15a - b show the extent to which the cardiac 
hypertrophy produced by the same three procedures could be 
attributed to the left ventricle. It is immediately 
apparent that all three treatments have increased left 
ventricular weight. In the case of thyroxine and iso­
prenaline treatment for 5 to 15 days the left ventricle 
still accounted for approximately a third of the heart 
weight, indicating that it had increased in the same pro­
portion as the rest of the heart. After coarctation 
however, the left ventricle accounted for almost half the 
weight of the heart. The heart weight after 10 days of 
constriction had increased roughly by Ig while the left 
ventricular weight increased by 0.95g, indicating that 
most of the growth occurred in the left ventricle. After 
21 days of aortic constriction the heart weight had in­
creased by 4.2g, while the left ventricular weight was 
increased by 2.45g. These results would seem to indicate 
that/..,
. TABLE 15a
TiiG left ventricular wet weight of sham operated and saline 
injected Californian rabbit at various time intervals*
Saline Inj ect e d
m m Noo of 
animals
Heart Height
(e)
5o?
+0.87
Left 'Ventricular 
_ _ _ _ _
2.00
+0.08
Ratio of 
Heart Height/ 
Left Ventricular 
Height
35
10 5.6
+0.66
1.99
+0.06
35
15 5.8
+0*78
2.03
+0.108
35
10
Sham, operated
5«6
+0.79
1o87
+0.03
33
21 5.8
+0.51
2.06
+0.100
35
Mean + SBu, Heart weight is given in (g)
TABLE 15b
"The effects of coarctation, thyroxine and isoprenaline on the 
left ventricular wet weight at various time intervals *
Treatment Days 3 0 of Heart Left ventricular Ratio of
animals \7ei "<ht Weight___ _ Heart W'ej.ght/
'  (gT ' (c) c-'ft ventricula: Y.hight
Controls 29 5*7
±0.72
1.99
±0 0 06
35
Coarctation 10 4 6*7
±0.70
2*95
±0*118
44
21 11 9*9 -X"X#
±0.95
4* 46 
±0.149
48
Thyroxine 5 7 5*3
±0.68
1.90
±0*07
36
10 7 6.7
±0.81
.2.36
±0*09
35
15 8 7.8 -X-x-x- 
±8 « 48
2.61 -%
±0*06
34
Iso­ 5 8 8*5 2.92 f+i- 33
prenaline
±0*68 ±0*100
10 6 8*2 4H<-*
±0 *83
2.69
±0.110
34
15 10 8.9 *** 
±0.99
3.01 +H!-* 
±0,08
36
Mean + SUi, Heart weight is given in (g), 0,05,
-îfxp <(0*01, 'îex-K-p-< 0*001
that growth had occurred in other chanibers of the heart, 
though not on the same scale as in the left ventricle.
In summary then, isoprenaline and thyroxine 
affected the whole heart whereas coarctation primarily 
affected the left ventricle.
2.1.3 Left Ventricular Wet and Dry Weight
It was obviously desirable at this time to 
ascertain whether left ventricular growth was due to 
increases in the wet or dry weight or both. An increase 
in dry weight would be a crude index of cellular growth. 
Tables 16a - b show to what extent increases in dry weight 
of the left ventricle paralleled the corresponding increase 
in wet weight. It is clear that the two are closely 
related to one another and the increases in dry weight did 
therefore represent a real increase in cellular growth and 
not merely an increase in water. These changes are found 
with the three methods used to induce left ventricular 
hypertrophy.
TABLE 'l6a
The Let and Dry v/eight of the left ventricle in the shaiu operated 
and saline injected rabbits at various time intervals.
Saline Injected
Da.ys No. of Let V/eiyht V/eiyht io V/et V/eivht
animals
5 5 1.60 0.40 80
+0.050 +0.009
10 6 1.55 0.40 78
+0.049 .±0.013
15 9 1.71 0.39 81
+0.036 +0.010
Sham Onerated
10 3 1.50 0.40 79
+0.44 +0.008
21 6 1.64 0.38 81
+0.053 +0.009
Mean + SIM
• TABLE I6b
, The effects of coarctation, thyroxine and isoprenaline on left 
venirj.cular wet and dry weight a/b various time intervals.
Treatment Days No. of Wet Weight Dry Weight fa Wet Weight
aiiimals (s) (c)
Controls 29 1.60 0.39 80
+0.046 +0.010
Coarctation 10 4 2,35 0«60 80
+0.054 +0,010
21 11 3o?8 0.68 84
+0,078 +0,015
Thyroxine 5 7 1«53 0.37 81
+0.02 +0.006
10 7 1.87 0,49 79
+0,06 +0.008
15 8 2,10 0,51 80
+0,041 +0,007
Isoprenaline 5 8 2*40 0,52 82
+0,039 +0.016
10 6 2,20 0.49 82
+0.068 +0.019
15 10 2.47 0.53 81
+0,071 +0.006
Mean + S M
DISCUSSION;
The experiments just described threw up two 
unexpected results which call for comment* The first 
is the increase in kidney size which follows constriction 
of the aorta* This may be tentatively attributed to 
liberation of growth hormone (Beznak 1964). The second 
is the fact that isoprenaline apparently exerts its 
maximum effect during the first five days of administra­
tion, although the dose is continually increased through­
out the entire fifteen days of the experiment. This is 
most easily explained if it can be assumed that the 
animals respond to the continued injections by increasing 
their ability in some way to metabolize isoprenaline.
In this connection it may be relevant that de Champlin et 
al, (1968) have shown that in congestive heart failure 
(which was proceeded by cardiac hypertrophy) monoamine 
oxidase activity was increased, while the levels of 
catecholamines was substantially lowered.
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2,20 Lactate Dehydrogenase Isoenzymes
The experiments described in the preceeding 
section established that authentic cardiac hypertrophy 
could be produced in rabbits. The next step was 
obviously to see how far this hypertrophy resembled the 
hypertrophy which was observed in human autopsy material. 
Tables 17a - b - c show the abundance of the five LDH 
isoenzymes in the left and right ventricles of Californian 
rabbits in which cardiac hypertrophy had been induced by 
each of the three techniques described in the preceeding 
section. Several points call for coimment. Although in 
the controls isoenzyme I predominated to a much greater 
extent than in human heart there was quite substantial 
proportions of II and III and though IV and V were present 
in least amount they were quite measurable (Fig. 3).
This is in agreement with Weiland et al (1959) and contrary 
to Plageman et al (19 60) and Markers and Appella (19 64) who 
claimed that only isoenzyme I is present in rabbit hearts.
The controls also showed two other interesting 
features; there was no progressive change in isoenzyme 
pattern as the sequence of saline injections was prolonged 
or as a result of sham operation at various time intervals. 
This corresponds to the fact (see Table 13a) that neither 
saline injections nor sham operations affected the heart 
weight, but there was a small but interesting difference 
between the ventricles; the predominance of isoenzyme I was 
slightly, but consistently, more marked in the left ventricle 
than in the right,
1/...
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1- Coarctation, The effect of coarctation of 
the aorta for either 10 or 21 days is to diminish somewhat 
the predominance of isoenzyme I, while isoenzymes IV and V 
v;as consistently increased in the left ventricle. The 
pattern in the right ventricle was altered in the same 
direction but to a lesser extent. This difference between 
the tw^ o ventricles can presumably be related to the fact 
that coarctation produced hypertrophy much more in the left 
than in the right. There is a suggestion that the effects 
in both ventricles were greater at 21 days than at 10 days,
2- Thyroxine, The isoenzyme pattern in both 
ventricles seemed little effected by thyroxine. There is a 
suggestion in both ventricles that the predominance of 
isoenzyme I was diminished to about the same slight degree 
and that this diminution was progressive, at least in the 
sense of being most évidents at the longest time interval. 
The isoenzymes IV and V at this point appeared to be 
increased in both ventricles.
3- Isoprenaline, This produced a very much more 
marked effect than either thyroxine or coarctation. In 
both ventricles, and to roughly equal degrees, isoenzyme I 
was depressed, especially at the expense of isoenzymes IV 
and V. The effect was fully developed at 5 days and showed 
no further increase between 10 and 15 days. In this it 
resembled the effect of isoprenaline on heart weight.
2.2.1 H & M Subunits
From the figures shown in Tables l^a - b it is 
possible to calculate the percentage of H and M sub-units 
of/,..
Fig. 3 The percentage of lactate
dehydrogenase isoenzymes 
from the left and right 
ventricle of control rabbit 
and the left ventricle of 
rabbits subjected to 
isoprenaline treatment for 
5 days or coarctation of 
the aorta for 10 days.
F'3
1
Left Ventricle B
Control
Right Ventricle 
Control
I n m  IV V
92.2 4 3.6 1.6 0
4- -  +
i n  ni IV V
89.2 4 4.1 2.0 0.7 %
w n  1 •
Left Ventricle 
Isoprenaline
n'^ ra'
82.7 6.8 6.4
Left Ventricle 
Coarctation
I H in IV V
86.4 5 5.6 2.5 0.4 %
-  + I
TAULHi' 17 a
The percentage of lacta.te dehydrogenase isoenzymes in the right 
and left ventricle of chani operated and saline injected Californian 
rabbits at various time intervalso
Sal i ne in j eî cted 
Hi ght ventri c1e 
ia LDH isoenzymesNo 0 of
Days animals I II III IV V
5 7 89,7 4oO 4,0 1.8 0,5
_j1 6 8 ±0.100 +0.110 +0.080 +0.013
10 5 86 o6 4o1 4.3 2.3 0o7
+2o1 ±0.180 +0.150 +0.067 +0.018
15 7 90 0 4 3.9 4.1 2.0 0,6
4^2 o 6 +0 « 146 +0.133 +0.059 ±0,016
Left ventricle
5 7 91.4 4oO 2.9 1,7 0
+3.0 +O0I66 ±0 ®144 +0.041
10 5 91.4 4.1 3.1 1 o4 0
±2.7 ±0.130 +0.151 +0.033 —
18 7 91.5 4oO 3.0 1,5 0
+2.7 +0.143 ±0.141 ±0.066
Sham operated
Eight ventricle
10 3 90.4 4.0 4.0 2,0 0.6
±2.9 +O0I6O +0,130 +0.090 +0.011
21 5 90.4 4.1 4.0 2.0 0.5
+2.7 ±0.150 +0.146 +0.065 +0,014
Left ventricle
10 3 91.4 4.0 3.0 1.6 0
+2o6 +0.121 +0.158 +0.049 •“
21 5 91.3 4.1 2.9 1,7 0
±2 e 8 +0.134 +0.101 +0.041
\ liean + SIM
TABLE 17b
The influence of coarctation, thyroxine end isoprenaline on the 
percentage of lactate dehydrogenase isoenzymes in the left ventricle 
of Californian rabbits at various time intervals
/^o LBH isoenzymes in left ventricle
Treatment Days No, of
Controls
Coarctation 10
Thyroxine 5
g.niinal s X II III IV V
27 91.4 4 3 1.6 0
+2,6 +0,149 +0.133 +0 0 046 -
4 86*1 5 6 2*3 0*4
+1*9 +0*133 +0.141
+-X-
±0.0^^ +0*013
21 11 86.2 ■ 4 6 2.9 0 .9
±2 * G +0*161 +0.149
-K-X-
+0.061 +0 0 016
■);
5 91.9 3.8 2*9 1.4 0
o 1 +0*131 +0.131 +0.039 ■“
10 9 91.8 4*2 3.1 1.5 0
+2*4 ±0.129 +0 * 146 +0*053
15 8 90.6 4.0 3.9 1.9 0,6
+2,7 +0*140 +0.140 +0*067 +0.017V.J*.
Isoprenaline 5
10
15 10
79.0 7*0 6.9 3.2 1.9
+2.9 +0.190 +0.183 +0.079 +0.021
-X- + •K--X-+ •/(■-X X
82.4 6*6 6.6 2.8 1,6
+2.1 +0.200 +0.144 +0.077 +0*018
Vi + -K +  X- -X
82.7 6*4 6.8 3.1 1,4
+2,7 +0 * 16 4 +0.178 +0.084 +0.020
-X. -X*
Kean _+ 0.05, **p<;o.oi,
#%%P<j0.001
TABI% 17c
The influence of coarctationp thyroxine and isoprenaline on the
pourcentage of lactate dehydrogenase isoenzymes in the pight ventricle of
Californian rabbits at various time intervals.
Treatment Days Noo of 
animals
io
I
LDH isoenzymes in right ventricle
II III IV V
Controls 27 89.3 4*0 4*1 2,0 0,6
+2 0 4 ±00154 +0.139 ±0.061 +0,013
Coarctation 10 4 90.6 4*8 3*9 2,1 0.4
±2o2 +0*167 +0,181 ±0,073 ±0,019
21 11 85*9 4.3 4*9 3o6 1*3
±3 * 4 +0,198 +8.179 ±0.091 ±0,021
Thyroxine 5 5 68*3 4*1 4.2 1.8 0.5
±2 * 9 +0*201 +0.195 ±0.066 ±0.016
10 9 86.3 4*4 5*3 2*9 1.1
+2.6 +0*179 ±0.169 ±0.073 +0*021
15 8 86.2 4*2 5*6 2.7 1.3
±2*7 +0.183 ±0,210 .’fO .114 ±1.108
Isoprenaline 5 5 81.7 5.0 7*2 4*2 1.9
10 5
±3 *0 
•>r
82.9
+0*194
4*9
+0.718
•x-y-
6.8
+0.114
*+;<-
3.8
±0.022
-X
. 1.6
15 10
+2.5
82,7
+0*210
4*6
±0.197
6.9
±0.088
•X-K-+
4.1
±0,019
y )\
1*7
+2 o B +0.188 +0.201 +0*094 ±0.019
Kean + Cldvi '>rp<0,05p "'
++->fp^  0*001 .
>^ p^ .(01; '
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of LDH in each ventricle* Tables 18a - b show the 
results of such calculations and these possibly demon­
strate more clearly the conclusion drawn from Tables 17a - 
b - Co The difference between the left and right ventricles 
of the controls in respect to M sub-units are readily 
noticable. After 10 and 21 days of aortic constriction 
the M sub-units in the left ventricle increased from 40 to 
6 7% at the expense of H sub-units. The proportion of M 
sub-units in the right ventricle was unaffected after 10 
days of aortic constriction, but after 21 days there was a 
significant increase of 32%. It is interesting that the 
non-stressed right ventricle, which was presumably not 
subject to overload^ should show a change in M sub-units. 
Similar changes were observed by SObel et al, (I9 60) and 
Bishop et al, (1969).
The percentage of M sub-units in both ventricles 
were little if at all effected by thyroxine treatment. The 
small effect that was observed did not occur until the 15th 
day, Isoprenaline, by contrast led to an immediate and 
much greater effect that coarctation or thyroxine. Both 
ventricles appeared to be effected to about the same degree.
In section I it was shown that in hypertrophied 
human hearts at autopsy a fall in the percentage of H sub­
units and the subsequent increase in M sub-units could be 
explained by fibrosis (i.e. an increase in the proportion 
of fibrosis tissue). Although in the rabbit experiment 
hypertrophy had been induced very much more rapidly than 
would have been the case in human patients, it is nonetheless 
tempting/...
TABIÆ; 18a
'The percentage of H and M snbunits of lactate dehydrogenase in 
the right and left ventricle of sham operated and saline injected 
Californian rabbits.
S aline-inj e c t ed
Days Ho c of 
animals Left
H
ventricle
M
subunits
Right
H
ventricle
M
5 7 96.3 3.7 95.2 4.8
10 5 96.5 3.5 94.4 5*6
15 7 96.7 3.6 94.9 5.1
Sham-operated
10 3 96.3 3o7 94.9 5*1
21 5 96.2 3.8 95.0 5.0
■ TABLE 18b
The percentage of H and î,î subimits of lactate dehydrogenase in 
the right and left ventricle following coarctation^ thyroxine and 
isoprenaline treatment in Californian, rabbits at va,rious time intervals.
Treatment 2 ^ No. of subunits
gjiimals Left ventricle righ'jgventricl
II M H 11
Control 27 96.3 3c7 94.8 5*2
Coarctation 10 4 93.4 6.6 95*0 5*0
21 11 92.3 7,7 92*5 7*5
Thyroxine 5 5 96.4 3.6 95*0 5*0
10 9 96.3 3*7 93.1 6.9
15 8 94.9 5.1 92,7 7*3
Isoprenaline 5 5 90.5 9 .5 90.1 9*9
10 5 91.2 8.8 90.9 9*1
15 10 91.2 8.8 90.5 9*5
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tempting to suppose that the changes in isoenzyme pattern 
again reflected an increase in fibrous tissue at the 
expense of heart muscle. This idea seemed particularly 
attractive since the greatest isoenzyme change was pro­
duced by isoprenaline^which would be expected to produce 
most fibrosis and the least change by thyroxine/which 
would be expected to produce little or none (page 44). 
Coarctation, which would be expected to produce an inter­
mediate degree of fibrosis produced an intermediate change 
in isoenzyme pattern. To establish the correctness of 
these ideas it was necessary to estimate the extent of 
fibrosis of rabbit hearts. This was done in the manner 
already described for autopsy material; it was assumed 
that the hydroxyproline content of the heart could be 
taken as a measure of collagen and collagen in turn could 
be used as a measure of fibrous tissue.
2.3.0 Fibrous Tissue in the Heart
The results are shown in Tables 19a - b . The 
controls results show that neither repeated saline injections 
or sham operations had any effect on the hydroxyproline con­
tent, There was however a consistently greater content of 
hydroxyproline in the ventricle than in the «
Coarctation for 10 and 21 days increased the hydroxyproline 
by 50%, The right ventricle showed a marginal increase 
after 21 days of constriction. Thyroxine appeared to have 
little effect, though such effect as it did produce was 
apparent in both ventricles and seemed progressive. The 
effects of isoprenaline were immediate and very much greater 
than/,,,
TA'BLE 19a
'The hydroxyproline content in the left and right ventricle of 
sham operated and saline injected Californian rabbit.
Saline injected
ngc hydroxyproline / mg, dry weight
Noo of
animals Left ventriclo right ventricle
5 7 2,31 2.93
+0,27 +0.33
10 4 2.18 3,09
+0,31 +0.28
15 10 2.46 3,15
+0,26 +0.39
Sham onerated
10 3 2.22 3.00
+0.34 +0.20
21 ,*11 2.50 3.11
•I'O * 44 ±0 *41
Mean + SEM
■ TABLE 19b
The effects of coarctation, thyroxine and isoprenaline on 
hydroxyproline in the left and right ventricles of californien 
rabbitSo
Treatment
Controls
No® of 
animals
35
ng, of hydroxyproline / mg, dry weight 
Left V entricle right ventricle
2.33
+0*33
3*06
+0*31
Coarctation 10
21 11
3*46
+0.45 
3*70 ^  
+0*61
3.01
±0*34
3.78
+0*37
Thyroxine
10
15
2.15
+0*29
2*20
+0.31
2*80
+0,58
2.81
+0*31
2.99
+0.29
3*70
+0.51
Isoprenaline 5
10
15
10
10
4.49 
±0 * 44 
4*30 -fHex-
+0.51
4*59
+0.39
4*10
+0.79
4*50 -X-# 
+0*63
4*49 
+0 * 48
Mean + SIM, *pC0.05, #%p^ t0*01, #*Xp/l0.001
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than those of either coarctation or thyroxine* The 
hydroxyproline content of both ventricles almost doubled 
in 5 days and shov/ed no further increase up to 15 days,
In every respect the parallelism between Tables 
18a “ b and 19a - b is extraordinary* An increase in 
M sub-units in Table 18b is paralleled by an almost 
proportionate increase in hydroxyproline (Table .19b).
The conclusion that LDH isoenzyme and the hydroxyproline 
content are reflections of the amount of fibrous tissue 
seems ineluctable.
2.31 Hist o1og1c a1 Examination
To put the issue beyond doubt^ sections of left
ventricle from animals subjected to coarctation and to
thyroxine and isoprenaline treatment were stained by 
Masson's method which stains collagen green. In addition 
to our own examination^ sections were examined by a path­
ologist who was asked to score therh for fibrosis (estimated 
on the amount of collagen and fibroblast) and necrosis 
(judged by the number of histocytes and other blood cells 
and vacuolisation of myocardial cells).
His report is shown in Table 20, Thyroxine showed 
perhaps the least effect. It caused little fibrosis and 
that only after 15 days. Necrosis appeared at 10 days and
only more marked after 15 days. Isoprenaline, by contrasty
produced marked fibrosis within 5 days which remained constant 
at 10 and 15 days. Necrosis was maximal at 5 days and 
thereafter diminished. Coarctation produced effects similar 
to, but less severe than, isoprenaline; moderate fibrosis 
was/...
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was apparent at 10 days and persisted to 21 days ; 
necfrosis was moderate at 10 days and diminished at 21 days * 
Two points emerge from these observations* First 
that the histological appearance of fibrous tissue runs 
parallel to the hydroxyproline estimations in Table 19a; 
and second, that in each of the three treatments, fibrosis 
was preceded by necrosis and presumably represented scarring 
or repair of the necrotic areas.
The relationship of fibrosis to the preceding 
necrosis is illustrated in Fig, 4 a - b - c - d - e ,  Fig,
4a and b are taken from control hearts. There is no 
obvious necrosis and only a moderate amount of collagen.
Fig. 4d shows a section taken from an animal treated with 
isoprenaline for 5 days. There is massive infiltration 
of the area with leucocytes and fibroblasts. In contrast 
with the controls, collagen appears to be localized and more 
prominent. Fig, 4c shows a section taken from an animal 
treated with isoprenaline for 15 days and therefore 
represents a later stage of the same process as Fig, 4d. 
There is less necrosis than in Fig. 4d and more collagen. 
Fig. 4e from an animal subjected to coarctation for 10 days, 
Necrosis is indicated by the number of vacuoles in the 
myocardial cells. At the same time there is a good deal 
of rather diffusely distributed collagen.
The main conclusions to be drawn from these histo­
logical studies is that the increase in fibrous tissue which 
appears in varying degrees to accompany experimental cardiac 
hypertrophy in the rabbit, is not merely a change in the 
relative/,,.
TABLE 20
* The extent of necrosis and fibrosis of the left ventricle 
following coarctation, thyroxine an.d isoprenaline treatment at 
varions time intervals*
Treatment Necrosis Fibrosis
Coarctation 10 ++ '{*+
21
Thyroxine 0
10 0 +
15 +
Isoprenaline ■+++
10 ++ +++
15
0 ~ no change, + = small change, -h - moderate change,
•H-+ marked change* At each time interval three californien 
rabbits were used*
Fig. 4a-b-c-d-e Sections of left ventricle from
Californian rabbits stained for 
collagen with Masson’s stain 
which appears green, counter- 
stained with Hamalum*
Fig. 4a Rabbit which was injected with
saline for 15 days. The normal 
appearance of muscle cells and 
collagen (Mag x 100).
Fig. 4b Rabbit which had undergone sham
operation for 21 days. The 
normal appearance of muscle cells 
and collagen (Mag x 100).
Fig. 4c Rabbit which was injected with
isoprenaline for 15 days. Increased 
collagen and vacuolization of 
muscle cells (Mag x 100).
Fig. 4d Rabbit which was injected with
isoprenaline for 5 days.
Increased collagen and round cells. 
(Mag X 100).
Fig, 4e Rabbit which had undergone
coarctation of the aorta for 10 
days. Increase in collagen and 
vacuolization of muscle cells 
(Mag X 100).
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relative proportions of different cell types in the 
myocardium; on the contrary it represents the replacement 
by fibrous tissue of more or less extensive areas of 
necrosis.
2.4.0 Serum Creatine Phosphokinase (SCPK) and Lactate
Dehydrogenase (SLDH) ._____________________ ______
If some degree of necrosis does accompany cardiac 
hypertrophy, one might reasonably expect it to be sign­
alised by the release of those enzymes which can normally 
be detected in the blood stream after myocardial damage, 
as for example, myocardial infarction.
Accordingly, SCPK and SLDH were estimated in the 
sera of rabbits which had been subjected to coarctation or 
to thyroxine or isoprenaline treatment. The results are 
shown in Fig. 5 and 6 for SCPK and SLDH, respectively.
To take SCPK first, since it is presumably more responsive 
to cell damage; coarctation led to a modest but substantial 
and quite unmistakable elevation throughout the period of 
the experiment. Thyroxine had little effect at first but 
after about 14 days the enzyme level showed a modest but 
significant rise. Isoprenaline, once again, provided a 
contrast. Within hours of its injection the enzyme showed 
a marked rise which was sustained for some days; but 
towards the end of the experimental period there was gradual 
fall back to the control level.
The results with SLDH ran roughly parallel to those 
with SCPK, Coarctation gave a sustained elevation starting 
from the second post-operative day. Thyroxine had no 
effect/...
Fig* 5 Serum Creatine Phosphokinase
levels at various time intervals 
following sham operation or 
saline injections (the controls) 
or isoprenaline and thyroxine 
treatment or coarctation of the 
aorta. Each point represents 
the mean + SEM of four 
Californian rabbits.
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Fig, 6 Serum lactate dehydrogenase
levels at various time 
intervals following sham 
operation of saline injection^ 
(the controls) or isoprenaline 
and thyroxine or coarctation of 
the aorta» Each point 
represents the mean + SEM of 
four Californian rabbits.
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effect initially but produced a rise towards the end of 
the experimental period, Isoprenaline produced an 
immediate and dramatic increase followed ultimately by a 
slow fall toward the control level, although this had not 
been reached by the end of the experimental period.
The results of these experiments therefore suggest 
that coarctation causes moderate but continuous damage to 
the myocardium, that thyroxine causes damage but only after 
administration for at least 14 days and that the damage 
caused by isoprenaline, though severe, is largely confined 
to the earlier part of the experimental period. This is 
in exact agreement with the histological observation shown 
in Table 20,
2.5. 0 Lysosomal enzymes
Since the results of SCPK and SLDH strongly 
suggested that cell damage accompanied cardiac hypertrophy, 
it seemed reasonable to look for confirming evidence. If 
cell damage does take place one would expect that lysosomes 
would play some part in this process.
The name lysosomes was proposed by de Duve et al, 
(1955 and 1959) for a group of cytoplasmic particles which 
contain a variety of acid hydrolases surrounded by 
membrane which acts as a barrier between the internal enzyme 
and the susceptible substrates present outside. It is now 
clear that lysosomes comprise a number of related entities 
which together form the main components of the digestive 
system within animal cells. Thus, lysosomes are implicated 
in the breakdown of material taken into the cell by 
endocytosis/,..
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endocytosis, that is, by any form of pinocytosis or 
phagocytosis* The main forms of lysosomes that can be 
distinguished are; the so-called primary lysosome, a 
storage granule for newly synthesized enzymes? the 
digestive vacuole or secondary lysosome, containing the 
engulfed material together with the enzyme; and the 
tertiary lysosome or residual body, characterized by 
various undigested remnants, usually either polymorphic 
or dense in appearance* A fourth type of lysosome, 
the autophagic vacuole^arises by an as yet poorly under­
stood intra-cellular process whereby a portion of cyto­
plasm, often including mitochondria, endoplasmic reticulum 
etc., becomes trapped inside a lysosome and undergoes 
digestion. This general process of digestion is shown in 
Fig, 11,
Quite apart from their role in the process of 
digestion, which can be regarded as a normal physiological 
event, lysosomes may be involved in the destruction of 
cells of which they form a part» de Duve et al (1959) has 
shown that lysosomal enzyme release during ischaemia in the 
liver results in cellular necrosis. However, recent 
investigations have cast doubt on the part lysosomal enzyme 
release plays in the onset of necrosis (Goldblatt et al, 
1965; Griffin et al, 1945; Bassi and Bernali-Zazzera,
1964; Slater et al, 1967), It is now generally believed
that lysosomal enzyme release plays a secondary rather than 
a primary role, with the one exception of photosensitisation 
(Slater and Riley, 1966; Allison et al, 1966), However, 
whether/,,,
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The inter-relationship of cytoplasmic granules functioning in 
intracellular.digestion of cells, as suggested by Gordon et al 
(1965),
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whether lysosomal enzyme action is primary or secondary 
to necrosis, it is generally agreed that changes in 
lysosomal permeability play an important role. Therefore 
an increase in the free or unsedimentable form of 
lysosomal enzymes would constitute prima facie evidence of 
necrosis *
An experiment was therefore performed to measure 
the relative proportions of the bound and free forms of 
ten characteristic lysosomal enzymes in heart homogenates 
after the induction of cardiac hypertrophy, A high ratio 
of bound to free enzyme would imply that the lysosomes are 
still intact and that the enzymes within are inaccessible 
to substrate; whereas a low ratio would indicate that the 
enzymes were being released*
Experiments by Raven et al, (1969) have already 
shown that if myocardial necrosis is induced in dogs by 
ligating the descending coronary artery, there is an 
accompanying increase in free lysosomal enzymes* The 
present experiments were intended to confirm and extend 
Raven’s observations. There were ten enzymes measured 
in this experiment which are typical lysosomal enzymes
Tables 22a - b show that the level of each enzyme 
in the free form was unaffected by saline injection or 
sham operation at various time intervals* Tables 23 - 
2 4 - 2 5  and Figs, 7 - 8 - 9  show the changes which took 
place when hypertrophy was induced by coarctation or by 
administration of thyroxine or isoprenaline. The pattern 
was remarkably uniform. Coarctation uniformly increased 
the/,,.
Fig. 7 8 " 9 The percentage of free 
lysosomal enzymes in the left 
ventricle of Californian 
rabbits following coarctation 
of the aorta or injections of 
thyroxine or isoprenaline. The 
numbers in the closed parenthesis 
represents the number of days of 
the above treatment. The broken 
lines represents the percentage 
of free lysosomal enzymes in the 
controls.
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the proportion of each enzyme which was in the free form* 
The increase was progressive in the same sense that it was 
more marked at 21 days than at 6 or 10 days* Similarly^ 
thyroxine produced a progressive increase in the pro­
portion of free enzymes* This increase was most noticable 
after 15 days of injection* By contrast, isoprenaline 
produced a much more abrupt response* The proportion 
of each enzyme in the free form increased sharply within 
24 hours and the increases in all cases were sustained to 
the fifth day. Thereafter, there was in most cases a 
decline toward the control level.
Taken by themselves these observations are clearly 
consistant with the hypothesis on which the experiment was 
based. They furnish further evidence of necrosis 
accompanying hypertrophy and they confirm that while the 
effect produced by isoprenaline is far more immediate and 
abrupt than those produced by coarctation and thyroxine, it 
is not qualitatively different*
Unfortunately this agreeably consistent picture is 
complicated if one examines the absolute amounts of bound 
enzyme in each case (i.e. enzyme presumably still locked in 
the lysosomes). It would be a reasonable assumption that 
when necrosis is accompanied by a release of lysosomal 
enzymes the increase in the free level of these enzymes 
should be accompanied by a fall in the bound level. In 
the present experiment this assumption was borne out only 
to a limited degree.
Twenty-four hours after the first isoprenaline 
injection/,..
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TABL:;] 23a,
The effect of coarctation of the aorta on lysosoiTial ens^ nne 
activity in the left ventricle of califorriian rabbits at varions lays
hnzymes
B-D-Galac t o s i das e
6 (2)
Free Boiind
0.48 0.43
4-0.014 4-0c011
10 (4)
Free Bound
0.53 0.45
±0,019 ±0,017
21 (11) 
Figg Bo\ind
0,59 0.62
,0.019 +0.024
B-D-Ct Incur oni do. s e
(4)
0.40 0.50 0,52 0.46 0.50 0.41
+0,013 4-0.021 +0.010 +0.026 +0.023 +0.019
N*“Ac G t y 1“ B™I)
Cr lucosaminidas e
'D-Mannosidase
0.81 1*5
+0.067 +0.095
0.29 0.46
+0.009 +0.014
1.6 1.5
+0.103 + 0.094
0.44 0.40
+0.013 +0.023
2.0 1.6 
+0.136 +0.148
'X'+4f
0.43 0.36
+0.021 +0.014
IF-D-CtIuc 0 si das e
64;
0.25 0.43 0,40 0.31 0.40
+0.016 +0.021 +0.024 +0.010 +0.016 +0.029
Lean + 831. Bnriber in the parenthesis equal number of experiments 
*p<L0.05; *%p<0.01, **+p2L0.001
A " mu moles phenol/rainute/mg, protein*
TABIh 23b.
The effects of coarctation of the aorta on lysosomal enzyme 
activity in the left ventricle of Californian rabbits at various days
Bays
5 (2) 10 (4) 21 (11)
Free Bound. lb?ee Bound F]:ee Bound
Esterase 0 .90 1 o6 %9 1.8 2.1
+0.091 +0.094 +0.014
■}f+
+0.160 +0.189 +0.175
Deoxyribonuclease
Acid
0.24
+0.019
0.39
+0.040
0.40
+0.018
0.31
+0.023
0.39
+0.021
0.34
+0.032
Acid Phosphatase 2 .4 1.8 3o3 1.6 3.4 2.0
W
+0 .140 +0.170 +0.180 +0.134 +0.201 +0.099
Phosphodiesterose 0,78 0.64 1,3 0.60 1.3 0,66
0\) +0,041 +0.038 +0.067 +0.051 +0.074 +0.066
Cathepsin ”B" 14 18 20 20 23 20
CcJ +1.0 +0.94 +106 +1.0 +10 3 +108
Mean + SEMo Muiabers in the parenthesis equal
number of experiments. 0.05; ■x-+p^  0.01.
A = mu moles phenol/rainute/mg protein
13 = increase in optical density (emit *= 0.100 OB) per hour/
rag protein
C = uc tyrosine/30 minutes/rag protein
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injection the rise in the free form of most of the enzymes 
studied was accompanied by an equivalent fall in the bound 
enzymes, so that there was no change in the total amount 
of enzyme» These changes presumably represent the 
"autolytic" process (i*e* change in lysosomal enzyme 
distribution of the existing cells). In every other case 
any increase in the free form of the enzyme was accom­
panied by an increase (albeit smaller) in the bound form* 
These changes would probably represent the "heterolytic" 
process (i.e. increased infiltration of phagocytic cells).
So therefore, the increase in total lysosomal enzyme 
activity may be related to an increase in other cell types 
which are rich in lysosomal enzymegy ^uch as phagocytic 
cells (Cohn and Hirsch, 1960),
2.5.1. Histochemical Observations
There is histochemical evidence however, that 
increases in lysosomes and their enzymes are associated with 
cardiac hypertrophy. Studies by Pearse (1964) and Van 
Noorden and Pearse (1970) haV^revealed histochemically that 
two lysosomal enzymes, acid phosphatase and non-specific 
esterase |Were increased in myocardial cells from patients 
with cardiac hypertrophy.
In an attempt to resolve this problem, histo­
chemical experiments were designed to find out where the 
increases in total lysosomal enzyme activity occurred (i.e. 
in myocardial cells or in other cell types) . The tv;o 
enzymes chosen for this purpose were acid phosphatase and 
N-acetyl-B-D-giucosaminidase. They were chosen because 
they are representative of lysosomes and because they 
showed/..o
-60"
showed an increase in total activity in the present 
experiment^.
Preliminary histochemical studies with acid 
phosphatase showed that the enzyme was increased in myo- 
cardiac cells during 10 and 21 days of coarctation and 
10 and 15 days of isoprenaline injections and 15 days of 
thyroxine injections* However, it was difficult to 
measure these changes. The other enzyme N-Rcetyl-B-D- 
giucosaminidase v/as not found at all in normal heart tissue, 
(fig, 10a) which is similar to the results of Hayashi 
(1964)„ These results may be related to the low levels 
of enzyme found chemically in heart tissue as compared to 
other tissue (i.e* liver and kidney) where this enzyme is 
found in appreciable amounts both histochemically and 
chemically. However, after coarctation for 10 days or 
21 days the enzyme could be demonstrated in the heart, but 
only in fibroblasts or cells of similar appearance which 
could not be unequivocally identified (fig. 10b). None was 
demonstrable in myocardial cells* After thyroxine treatment 
the enzyme was again found only in fibroblasts and similar 
cells and only after 15 days (fig* 10c)* After isoprenaline 
treatment it was demonstrable at 5 and 15 days, once again 
only in fibroblasts and similar cells (fig.lOgh). Fibro­
blasts arOyOf course, much less numerous than myocardial 
cellsy and it is quite conceivable that, although the 
individual myocardial cell might contain much less N-Acetyl- 
B-D-^lucosaminidase than the individual fibroblast, all the 
myocardial cells taken together might contain a total more 
of/,,.
Fig"c lôa-b-c-d-e-f-g-g Sections of the left ventricle from
Californian rabbits incubated for 
N”Acetyl-B-D-Glucosaminidase 
activity with Naphthol AS-BI-N™ 
Acetyl-'B-D-Glucosaminide as substrate 
and hexazotized p-rosaniline as 
coupler for GO min* at 37°C pH 4.5* 
The reaction product appears red at 
the site of enzyme activity*
Fig,15a Rabbits which were injected with
saline for 15 days. Note no reaction 
product inside myocardial cells. 
However there appears to be some 
reaction product in or near an 
arteriole (Mag x 250),
Fig* 1.5b Rabbit which had undergone sham
operation for 21 days* Note no 
reaction product inside the myo- 
cardiac cell, (Mag x 1000).
|0
m m
ftr..”.
A
B
Fig.10c Rabbit which had undergone
coarctation of the aorta for 10 
days o Note the reaction product 
appears in fibroblasts or cells 
with similar appearance (Mag x 1000)
Fig*IDd Rabbit which had undergone
coarctation of the aorta for 21 days 
Note reaction product only appears 
in fibroblast or cells with similar 
appearance (Mag x 1000).
F,g 10
C
u
Fig.lQe-f Rabbits injected with thyroxine
for 15 days. Note reaction product 
appears only in fibroblast or 
cells of similar appearance 
(Mag X 250)„
F'5
^ k c È t # K % ; z A t
w m
-^ '=5WC:
£.
3
Fig.lOg Rabbit injected with isoprenaline
for 5 days. Note reaction product 
only appears in fibroblast or cells 
of similar appearance (Mag x 1000)
Fig.lOh Rabbit injected with isoprenaline
for 15 days. Note reaction product 
only appears in fibroblast or cells 
of similar appearance (Mag x 1000),
F'j
|0
f
0
%
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V V-
i
H
“■ 61
of the enzyme than all the fibroblasts taken together,
2.5.2 Ground Substance
Since N-#petyl-B-D-glucosaminidase was found to be 
increased it seemed reasonable to determine if its pre­
sumptive substrate changed in cardiac hypertrophy. In 
the myocardiumf ground substance^ which generally contains 
mucopolysaccharides and/or glycoproteins are presumed to 
be the substrate of N-#petyl-B-D-giucosaminidase in vivo 
(Fibian 1966). An attempt v/as therefore made to detect 
chemically and histochemically mucopolysaccharides and 
glycoproteins in the heart following experimentally induced 
cardiac hypertrophy.
Histochemically^ acid mucopolysaccharides stain blue 
using the method of Hale (1948). In the normal heart it 
was demonstrable in the intra-cellular ground substance, 
between collagen fibers but in very small amounts (fig.
12a); after coarctation it was clearly increased at 10 
and not at 21 days (fig. 12b and Table 27): after 5 days
of thyroxine treatment no change was apparent but after 15 
days there was a small increase (Table 27)? isoprenaline 
produced a marked increase at 5 days which had diminished 
at 15 days (fig, 12c and Table 27).
A parallel chemical estimation involved measuring 
glucosamine^which is normally a major constituant of muco­
polysaccharides and glycoproteins. The results found in 
Tables 2 6a - b are roughly parallel to those found histo­
chemically. There were slight increases at 6 and 10 days 
with coarctation and at 15 days with thyroxine? a much more 
dramatic/,..
Fig. 12a-b-c Sections of the left ventricle
of Californian rabbits stained 
for acid mucopolysaccharides 
with Hale stain which appears 
blue, and stained with Van 
Gieson's stain, counterstained 
with Hamalum.
Fig. 12a Rabbit injected with saline for
15 days. Note spearse acid 
mucopolysaccharides (Mag x 100)
Fig, 12b Rabbit which had undergone
coarctation of the aorta for 10 
days. Note accumulation of acid 
mucopolysaccharides (Mag x 100).
Fig. 12c Rabbit injected with isoprenaline
for 3 days. Note the marked 
increase of acid mucopolysaccharides 
(Mag X 100)o
JA
c.
TABLE 27
The extent or change in mucopolysaccharide of the left ventricle 
following coarctation, thyroxine and icomrenaline treatment a/t variouc 
t'line intervals «
Treatment Ba\n } A3 c o p o 1 y s a c r f ’ c d e b
Coarctation 10
21 0
Thyroxine 0
10
15
Isoprenaline
10
15
0 = no change, + - small change, T-f- moderate change,
-H4- == marked change. At each time interval three californien 
rabbits were used..
TABLE 26a
The hexosamine content In the left ventricle of sham 
operated and saline injected californien rabbits at various time 
intervals &
Saline injected
NOo of Hexosamine in mg,
animals - (as G-l.ncoBa'nlne HCL)/go Dry V'eighi
3 2.1
+0.20
5 8 2.2
+0,22
10 4 2.2
+0,23
15 10 2.2
+0.18
Sham onerated 
6 2 2.2
+0.24
10 4 2.2
+0.19
21 4 2.1
+0.22
TABLE 26b
The effects of coarctation, thyroxine and iaopreanline 
treat'..ent on the amount of hcxosamine in the left ventricle at 
various time intervals.
Treatment
Controls
Ko o of 
animals
30
Lexosamino in mg,
(as Glucosamine ]ICL)/g, Dry height
2*2
+0,21
Coarctation 6
10
21 11
2 c6 
+0o26
3.1 *  
+0.21 
2.0 
+0.29
Thyroxine
10
15 10
2.1
jkO o 24
2.3
+0,20
2.7
+0.19
Isopreanline 3
10
15 13
Lean + SIM #p<0.01/C **u< 0.001
3*7 -%-* 
+0,28 
3.5
+0.31
2.4
+0.26
1.9
+0.20
— 62 —
dramatic effect at 3 and 5 days with isoprenalinewhich 
subsequently diminished.
These results by themselves are interesting but 
difficult to interpret. They follow a pattern which we 
have already noted repeatedly in these experiments in 
that isoprenaline showed a large and immediate effect 
which subsequently diminished, while thyroxine showed a 
smaller and progressive effect and coarctation same 
somewhere in between*
The histochemical results for N-&cetyl-B-D- 
01ucosaminidase seemed to have nothing to do with the 
myocardial cell, but reflected the behaviour of fibro­
blasts or similar cells. This threw doubt on the whole 
idea that changes in lysosomal enzymes in cardiac hyper­
trophy have anything to do with myocardial cells. This 
doubt could only be resolved by the electron microscope. 
2.6.0 Electron Microscope Observation
The early phase of lysosomal research was based 
mainly on the biochemical analysis, however in recent years 
cytochemical methods and electron microscopy have con­
tributed to our understanding of the subject. Such 
observations have mostly been confined to liver, although 
Abraham et al, (1967) observed lysosome-like veiscles in 
the perinuclear region of heart muscle. These vesicles 
were subsequently isolated by Hendley et al, (1965) and 
shown to contain a typical lysosomal enzyme^ Cathepsin D.
In the present study, sections of the left ventricle were 
prepared for electron microscopic observation. Figures 
13a - b “ c - d show the normal appearance of the left 
ventricle/,..
Fig. 13a Myocardial fiber from left
ventricle of rabbit injected with 
saline for 15 days. (MY) myofibril, 
(ID) intercalated disc, (M) mito­
chondria, the arrow points to 
sarcotubular system (Mag x 25,000).
Fig. 13b Myocardial fiber from left ventricle
of rabbit which had undergone sham 
operation for 21 days. (ID) inter­
calated disc, (M) mitochondria,
(ER) endoplasmic reticulum, (Z) Z 
band, (S) S zone, the arrow points 
to pinocytic vacuoles (Mag x 25,000)
Fig. 13c Myocardial fiber from the left
ventricle of rabbit which had under­
gone sham operation for 10 days.
(F) fat droplets, (DV) dense 
vesicle, (GV) golgi vesicle, (N) 
nucleus, (ER) rough sarcoplasmic 
reticulum (Mag x 25,000).

tFig* 13d Myocardial fiber from the left
ventricle of rabbit injected with 
saline for 5 days. Arrows point 
to the sarcotubular system 
(Mag X 25,000).
Fig. 13e Myocardial fiber from left
ventricle of rabbit which had 
undergone sham operation for 21 
days. Arrows point to the sarco- 
tubular system (Mag x 25,000).
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ventricle. Only a fev; structures could reasonably be 
identified as lysosomes, one such is shown in Fig. 13c.
It has a dense matrix surrounded by a membrane. Similar 
structures have been described in a variety of tissues 
under the names "dense vesicles" or "lipofuchsin 
granules ^ " (Novikoff, 1963). It is generally accepted 
that they are tertiary lysosomes or residual bodies as 
defined above. However, for the present, it is perhaps 
better to use the more non-committal description term 
"dense vesicle." In the normal myocardial cell the few 
dense vesicles observed were confined to the perinuclear 
region.
After coarctation of the aorta for either 10 or 21 
days, many more dense vesicles could be seen in myo­
cardial cells, not only around the nucleus but throughout 
the cytoplasm. No obvious difference could be seen between 
sections taken at 10 days and 21 days. Some examples are 
shown in fig. 14b - d. It was observed that about a fifth 
of the dense vesicles contained what looked like fa.t 
droplets (fig. 14d).
After thyroxine treatment for 5 days no increase in 
dense vesicles could be detected. However, 15 days of 
thyroxine treatment led to an increase similar to that seen 
after coarctation. As after coarctation^the vesicles were 
found throughout the cytoplasm and not merely around the 
nucleus (fig. 14a) and about a fifth contained fat droplets.
After isoprenaline treatment for 5 days there was 
an increase in dense vesicles greater than that produced by 
either coarctation or thyroxine. Again about one fifth 
contained/,..
Fig. 14a Myocardial fiber from the left
ventricle of rabbits injected 
with thyroxine for 15 days. Arrows 
point to dense vesicle (Mag x 2 5,000)
Fig. 14b Myocardial fiber from the left
ventricle of rabbit which had 
undergone coarctation of the aorta 
for 10 days. Arrows point to 
dense vesicle (Mag x 25,000).
Fig. 14c Myocardial fiber from the left
ventricle of rabbit injected with 
isopreanline for 5 days. Arrows 
point to dense vesicle (Mag x 25,000).
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Fig. 14d Myocardial fiber from the left
ventricle of rabbit which had 
undergone coarctation for 21 days 
(DV) dense vesicle, (ER) rough 
sarcoplasmic reticulum, (F) fat 
droplets (Mag x 2 5,000).
Fig, 14e Myocardial fiber from the left
ventricle of rabbit injected with 
isoprenaline for 15 days. (DV) 
dense vesicle, (M) mitochondria, 
(F) fat droplets, (ER) rough 
sarcoplasmic reticulum, (GV) 
golgi vesicle (Mag x 25,000).
Fig. 14f Fibroblast from the left ventricle
of rabbit injected with isoprenaline 
for 5 days, (DV) dense vesicle 
(Mag X 25,000).
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contained fat droplets, and again they were distributed 
throughout the cytoplasm and not merely around the nucleus 
(fig. 14c - e), The picture after 15 days of iso­
prenaline treatment was not essentially different.
Because the electron microscope can be used to 
examine only an infinitesimally small sample of tissue, it 
can seldom by itself be the basis of quantitive conclusions. 
In the present instance however, the marked increase in the 
number of structures which can safely be identified as 
lysosomes is sufficient to justify the view that the 
changes observed in lysosomal enzymes in the heart are 
largely explicable in terms of events in the myocardium. 
Although other cell types may play some role in altering 
the enzyme pattern of the heart as a whole, there is no 
reason to suppose that it is a predominant one.
In the course of the search for electron microscopic 
evidence of lysosomes in the myocardium, a number of other 
structural changes were observed to accompany hypertrophy. 
Thus, although the appearance of dense vesicles was the 
most striking evidence for the presence of lysosomes, a 
smaller number of autophagosomes or secondary lysosomes 
were also observed after hypertrophy. These structures 
were never encountered in the normal myocardium. As was 
explained above, autophagosomes are vesicles which contain 
part of the cytoplasm which, apparently, they digest. 
Autophagosomes are normally found in cells which are 
involved in cellular necrosis (Deter and de Duve, 1967? 
Ericsson/.,.
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Ericsson et al, 1967? Trump et al, 1962, 1965).
After coarctation they were seen in almost equal numbers 
at 10 and 21 days (fig. 15a). After thyroxine none 
were seen at 5 days and only a few at 15 days. After 
isoprenaline they were seen at 5 days in greater numbers 
than after coarctation, (fig. 15b- c -) but they had 
disappeared at 15 days. If the autophagosome can be 
regarded as a lysosom&5 actively engaged in cell 
destruction, these observations would fit in with the 
view derived from the earlier experiment in the present 
work, that all three methods used to produce hypertrophy 
cause cell destruction? that it is slow and progressive 
in the case of thyroxine? and the effects of coarctation 
lie between these extremes.
One might perhaps expect that this cell destruct­
ion should be evident from electron microscope studies and 
it is true that in general the hypertrophic hearts, no 
matter how the hypertrophy had been produced, seem to 
show disorientation of myofibrils and swelling of mito­
chondria. It is however difficult to be certain that 
both of these are not due to artefact in preparing the 
tissue for the electron microscope (Maser et al, 1967).
There is on the other hand clear evidence of 
increased protein synthesis.
Rough sarcoplasmic reticulum, which is rare in normal 
myocardium, (Fawcett and McNutt, 196 7) shows a marked 
increase 10 or 21 days after coarctation (fig. 16a - b), 
after 5 or 15 days of isoprenaline treatment (fig. 16c - 
d) and/,,,
Fig. 15a Myocardial fiber from the left
ventricle of rabbit which had 
undergone coarctation of the 
aorta for 10 days. Arrows 
point to autophagosome 
(Mag X 25,000).
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Fig. 15b Myocardial fiber from the left
ventricle of rabbit injected 
with isoprenaline for 5 days.
(AU) autophagosome (Mag x 25,000)
Fig, 15c Myocardial fiber from the left
ventricle of rabbit injected with 
isoprenaline for 15 days (X) an 
autophagocytic vacuole inside an 
autophagosome, (MB) membrane of 
the autophagosome, (AU) auto­
phagosome (Mag X 25,000),
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and after 15 days of thyroxine injection (fig. 16e).
It is not however increased after 5 days of thyroxine- 
What proteins are synthesized by this additional 
machinary is, of course, an open question? it may be 
for new myofibrils or it may be for new lysosomes.
In parallel with these changes in the myo­
cardial cells the fibroblasts and endothelial cells 
showed increases in rough endoplasmic reticulum. As 
compared to the control'this was found in increased 
amounts at 10 and 21 days of coarctation (fig. 17b), 
after 5 and 15 days of isoprenaline (fig. 17a) or 15 
days of thyroxine (fig. 17d) but not after 5 days of 
thyroxine injections. In fibroblasts, rough endoplasmic 
reticulum can perhaps be implicated in the synthesis of 
glycoprotein and/or collagen. It is more difficult 
however, to understand what may be happening in the 
endothelial cells (fig. 17c).
All the electron microscope findings discussed 
up to this point can plausibly be related to either cell 
destruction or cell growth, but there is one outstanding 
feature of the electron microscope evidence which cannot 
be completely related to either? all the hypertrophic 
hearts showed a substantial increase in the number of 
lipid droplets in the myocardial cells- This was 
visible to a roughly equivalent extent at 10 and 21 days 
after coarctation (fig. 18a). In many cases these 
lipid droplets were in contact with one or more mito­
chondria. Sometimes they were actually inside the mito- 
chondron and in these cases there was invariably a 
contiguous/,,,
Fig. 16a Myocardial fiber from left
ventricle of rabbit which had 
undergone coarctation of the aorta 
for 10 days. (DV) dense vesicle, 
the arrow points to rough sarco­
plasmic reticulum (Mag x 25,000).
Fig, 16b Myocardial fiber from left
ventricle of rabbit which had 
undergone coarctation of the aorta 
for 21 days. (F) fat droplet, the 
arrows point to rough sarcoplasmic 
reticulum (Mag x 25,000),
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Fig. 16c Myocardial fiber from left
ventricle of rabbit injected with 
isoprenaline for 15 days. Arrow 
points to rough sarcoplasmic 
reticulum (Mag x 25,000).
Fig, 16d Myocardial fiber from left
ventricle of rabbit injected with 
isoprenaline for 5 days. Arrow 
points to rough sarcoplasmic 
reticulum (Mag x 25,000).
Fig, 16c Myocardial fiber from left ventricle
of rabbit injected with thyroxine 
for 15 days. Arrow points to rough 
sarcoplasmic reticulum. (Mag x 25,000)
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Fig, 17a Fibroblast from the left ventricle
of rabbit injected with isoprenaline 
for 5 days a Arrow points to 
rough oplasmic reticulum
(Mag X 25,000).
Fig. 17b Fibroblast from the left ventricle
of rabbit which had undergone 
coarctation of the aorta for 10 
days. Arrow points to rough
oplasmic reticulum (Mag x 25,000),
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Fig, 17c Endothelial cell from left ventricle
of rabbit injected with isoprenaline 
for 5 dayso (BC) red blood cell.
The arrow points to rough endoplasmic 
reticulum ,(Mag x 25,000).
Fig. 17d Fibroblast from left ventricle of
rabbit injected with thyroxine for 
15 days. (N) nucleus, arrow points 
to rough endoplasmic reticulum 
(Mag X 25,000).
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contiguous clear space, sometimes indeed completely 
surrounding them, as though the cristae had been destroyed. 
After 5 days of thyroxine administration there appeared 
to be fewer lipid droplets than after coarctation and 
correspondingly fewer within mitochondria (fig. 18c). 
Qualitatively, however, the picture was the same as after 
coarctation. After 15 days of thyroxine treatment the 
number of lipid droplets had increased the the general 
picture was idential with that seen after coarctation 
(fig. 18b)o The effects of isoprenaline at 5 and 15 days 
were again qualitatively similar to those of coarctation 
but seemed even more marked (fig. 18d - e). The signifi­
cance of these findings will be discussed later.
Apart from the features common to all three, coarc­
tation, thyroxine and isoprenaline, each produced its ov/n 
peculiar electron microscope pattern. Thus, coarctation pro­
duced after 10 and 21 days a characteristic deformation of 
the Z line from its normal rectilinear appearance and a 
corresponding deformation of the intercalated disc (fig. 19a- 
b). Similar findings have been reported by Bishop and Cole, 
(1969). Thyroxine treatment at 5 and 15 days produced a 
marked increase in the numbers of mitochondria (fig.. 20a - b) . 
Perhaps, in view of the known action of thyrxoine on metabol­
ism in general this is hardly unexpected. Isoprenaline 
treatment at 5 and 15 days led to the appearance in some 
myocardial nuclei of what might be called inclusion bodies 
(fig, 21a - b). These were never seen in the myocardial 
nuclei of the control animals or of animals which had under­
gone coarctation or been treated with thyroxine. The sign­
ificance of these findings is obscure.
Fig. 18a Myocardial fiber from left
ventricle of rabbit which had 
undergone coarctation of the aorta 
for 21 days. Arrows point to 
lipid droplets inside and outside 
the mitchondria. (Mag x 25,000).

Fig. 18b Myocardial fiber from left
ventricle of rabbit injected 
with thyroxine for 15 days.
(F) fat droplets, (N) nucleus 
(Mag X 25,000).
Fig. 18c Myocardial fiber from left
ventricle of rabbit injected 
with thyroxine for 5 days,
(F) fat droplets, (M) mito­
chondria (Mag X 30,000).
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Fig, 18d Myocardial fiber from left
ventricle of rabbit injected 
with isoprenaline for 15 days 
(F) fat droplets, (M) mito­
chondria (Mag X 2 5,000).
Fig. 18e Myocardial fiber from left
ventricle of rabbit which had 
undergone coarctation of the 
aorta for 10 days. (F) fat 
droplets, (M) mitochondria,
(GV) Golgi vesicles, (N) nucleus 
(Mag X 30,000).
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Fig, 19a Myocardial fiber from left
ventricle of rabbit which had 
undergone coarctation of the 
aorta for 21 days. Arrows 
point to altered Z bands and 
intercalated disc (Mag x 25,000)
Fig, 19b Myocardial fiber from left
ventricle of rabbit which had 
undergone coarctation of the 
aorta for 10 days. Arrow 
points to disorientation of 
myofibril (Mag x 25,000).
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Fig, 20a Myocardial fiber from left
ventricle of rabbit injected 
with thyroxine for 5 days.
(F) fat droplets, (M) mito­
chondria, Arrows point to 
pinocytic vacuoles in myo­
cardial and fibroblast 
(Mag X 20,000).
Fig, 20b Myocardial fiber from left
ventricle of rabbit injected 
with thyroxine for 15 days. 
(N) nucleus, (L) lipid, (ME) 
mitochondria, (DV) dense 
vesicle (Mag x 15,000).
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Fig. 21a Myocardial fiber from left
ventricle of rabbit injected 
with isoprenaline for 5 days.
(N) nucleus, arrow points to 
inclusion body inside the nucleus 
(Mag X 25,000),
Fig. 21b Myocardial fiber from left
ventricle of rabbit injected with 
isoprenaline for 15 days. (Nj 
nucleus, arrow points to inclusion 
body inside the nucleus.
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2.7.0
Lipid Metabolism During Cardiac Hypertrophy
The increase in fat or lipid droplets seen in the 
electron microscope in hypertrophy produced by all three 
procedures obviously required confirmation and extension 
by other methods. Tables 28a - b show the total lipid 
concentration in the left ventricle. As with all the 
other measurements it is unaffected by injections with 
saline and by sham operation. Coarctation produces a 
marked increase after 10 and 21 days. Thyroxine pro­
duces a progressively greater increase as treatment is 
prolonged for 5 days to 15 days, and isoprenaline pro­
duces an immediate increase at 5 days which gradually 
diminishes. This is analogous to the pattern of response 
shown in many of the other parameters measured in the 
present study, but there is an unusual feature. Normally 
the effects of thyroxine not only developed more slowly 
than those of coarctation and isoprenaline but at the end 
of the 15 days experimental period they were generally 
smaller than the maximum effects seen with either coarc­
tation or isoprenaline. In the present instance, however, 
thyroxine produces a greater increase than either coarc­
tation or isoprenaline.
Tables 29a - b show the corresponding figures for 
glyceride glycerol which may be taken to be proportionate 
to triglyceride. It is clear that these results are in 
parallel to those for total lipids.
Figures 22a - b - c - d show the results of an 
experiment which was intended to provide histochemical 
confirmation/...
TABLE 28a
The total lipid in the left ventricle of cliam operated and 
;aiine injected Californian rabbits at varions time intervals*
NOo of î,lg._/lpid / ^
animals
5 4 20
+j oh
10 4 • 20
±2 • 4
15 4 20
+2.0
Sham operated
10 4 20
±1.9
21 4 21
+2.4
Mean + S'.ïi,î
TABLE 2ob
The influence of coarctation? thyroxine and iocyrenaline on 
total lipid in the left ventricle of Californian rabbits at various 
tijae int erval s «
Treatment Bays IToo of hr;, lipid / g. net weifyht
animals
Controls - 20 20
Coarctation 10 4 32
_*j^2 « 6
21 5 53 *
+2 e 4
Thyroxine 5 5 28
10 7 41
±3*4 ■
15 10 45 '%*
+3*6
Isoprenaline 5 5 40
T3 o B
10 8 38 -X-
+2,6
15 9 30 *
±2.3
Eean ± SEIi ap^O.OI, *#p<:0.001
TABLE
n Glyceride Glycerol in the left ventricle of shaan operated and 
saline injected californian rabbits at various time intervals.
Sa.'J.ine in:j cot ed
Days NOo Of /a, moles Glyceride Glycorol/g. jM'et__^T,’£ight
animals
5 4 1066
±0.034
10 4 1*60
±0.045
15 4 1*62 r>
+0,029
Sham operated
russU'rrA'W.A-tfcd^ ’^V^OViV^.imM.TM'ttrutUiniirt^in
10 4 1.60
±0.033
21 4 1.62
±0.030
he an >!• SEF-,1
TABIE 29b
T he effects of coarctation, thyroxine and isoprenaline on
Glyceride Glycerol in the left ventricle of californian rabbits at
various time intervals®
Treatment Days No. of yU moles Glyceride Glycerol/g. net roi.yht
animais
Controls - 20 1*62
±0.033
Coarctation 10 A 2*98 #
±0.1310
21 5 2.89 4(-
±0.0967
Thyroxine 5 5 2.34
±0.063
10 7 ' 4,53
±0.173
15 10 4*73
±0.166
Isoprenaline 5 5 4*80
±0.213
10 8 3s86 -x-M-
±0.101
15 9 3,87
±0.096
Llean + S.1M *p 0.01, 0.001
Fig. 22a“b“C~d Sections of the loft ventricle
of californian rabbits stained 
for lipid droplets with Oil Red 
"0” which appears as- red droplets 
inside the myocardial cell, 
counterstained with Hamalum,
Fig. 22a Rabbit injected with saline for
15 days. Note the occasional 
lipid droplet inside the myocardial 
cell (Mag x 100).
Fig. 22b Rabbit which had undergone
coarctation of the aorta for 21 
days. Note the accumulation of 
lipid droplets (Mag x 400)
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Fig, 22c Rabbits injected with thyroxine
for 15 days. Note marked increase 
in lipid droplets inside the 
myocardial cell. (Mag x 250).
Fig. 22d Rabbits injected with isoprenaline
for 5 days. Note marked lipid 
accumulation inside the myocardial 
cell (Mag x 400).
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confirmation of the chemical results shown in Tables 2 8a - 
b and of the electron microscope findings of lipid 
droplets in myocardial cells. For this purpose, sections
of left ventricle were stained with Oil Red O" which
shows lipid as discrete red droplets. It is quite clear 
that all three treatments have caused accumulation of 
lipid in the myocardial cells. This was moderate in the 
case of coarctation (fig. 22b); progressively.becoming 
more marked with thyroxine (fig* 22c) and initially severe 
but becoming less with isoprenaline (fig. 22d).
2*7*1 Serum Free Fatty Acids
Since lipid in the form of free fatty acids is 
the major energy source for the heart increase in lipid 
in the hypertrophic myocardium seemed to warrant an 
investigation of the levels of free fatty acid in the 
serum. The results are shown in Fig. 23. Coarctation 
had no significant effect in either the short term or the 
long term. Thyroxine had no effect for the first six 
days but thereafter produced a modest but consistent 
increase. Isoprenaline produced an increase in a matter
of hours. This was sustained up to the sixth day, after
which there was a return to the control level.
The fact that thyroxine and isoprenaline both, 
though in different ways, raise FFA, whereas coarctation 
does not, may be related to the previous observation 
(Table 2 8b) that though all three treatments cause lipid 
accumulation in the heart, thyroxine and isoprenaline d- 
so to a greater extent than coarctation. However that may 
be/* «•
Fig, a  3 Serum free fatty acids at 
various time intervals 
following sham operation or 
saline injections (the controls) 
or isoprenaline and thyroxine 
treatment or coarctation of the 
aorta. Each point represents 
the mean + SEM of four 
californian rabbits.
V-R<m path y AciRsTml. 
Aà Howas ‘
8
I
<
m
KH
g
3
?
4'
?
■ %
3ip
roCK
~7Q:
may be/the fact that lipid accumulation does occur
after coarctation shows that it is not entirely a
result of raised FFA levels but is to some extent a
feature of the process of hypertrophy itself.
2 .8.0
Lactate Acid in the Myocardium
The results obtained up to this point provide a 
fairly detailed picture of the differences^ structural 
and chemicalf between normal and hypertrophic hearts.
They throw little light however on the mechanism by 
which these differences are produced. A starting point 
in the search for such a mechanism might be the demon­
stration (fig. 7 8 “ 9) that liberation of lysosomal
enzymes is a feature common to the hypertrophy produced 
by all three treatments. Such a liberation might result 
from hypoxia and consequent accumulation of lactic acid 
with a concomitant fall in pH (De Hann and Field, 1959). 
This hypothesis is open to simple experimental test.
Table SOa - b shows the level of lactate in the right and 
left ventricles.
All three treatments appear to have characteristic 
effects? coarctation approximately doubled the lactate 
concentration in the left ventricle within 5 days of the 
operation and this increase is sustained at 10 and 21 days 
There is little or no corresponding increase in the right 
ventricle, which probably reflects the fact that coarc­
tation, as we have seen (Table 15b), causes hypertrophy 
primarily of the left ventricle.
The effects of thyroxine are quite different.
From/.c o
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Front day 3 to day 15 there is a slow parallel increase in 
the'lactate, concentration in both ventricles.
Finally isoprenaline, as usual, produces the most 
dramatic effects. After one day there was significant 
increases in both ventricles though the increase in the 
left is much greater (200%) that that of the right (50%). 
Thereafter the levels in both ventricles gradually 
returned towards the normal level.
TAl&h 3 0GL
The lactate concentration in the left and ri^ht ventricle of 
sham operated and saline injected californian rabbits.
Saline injected
_ ma. of lactic acid / 100g. wet weightHo. of ^
animals Left ventricle Right ventricle
1 3 12.1 8o6
±1.3 ±0.65
3 3 9.3 10.3
±0 o 95 ±1 * 4
5 4 10.6 9.2
± 1.0 ±0.99
10 4 14 7o8
±16 6 ±0.91
15 5 11*1 10.0
+1*3 +0.87
Sham operated
5 2 10.9 11.3
±1o4 ±1•9
10 3 11.4 10.6
±1 » 2 ±1.6
21 6 11.8 9.6
± 1.0 ±0.96
Lean + Gm. «
TABIF O  h
The effects of coarctation ? thyroxine and isoprenaline on 
lactate concentration in the left and right ventricle of californian 
rabbits at varions time intervals.
Ihea1:ment 'Days
Controls
Coarctation 5
10 
21
Thyroxine 1
3 
5 
10 
15
Isopreanline 1
Ko. of 
animals
30
mg. of lactic acid / 100g, ret -veicht
10
15
I,eft ventricle
11.4 
±1.2
23.0 ** 
±2"3 
20,8 **
±1.8 
20.6
+2 .6
8.3
+1o1 
8,0 
+0,98 
9.1 
±1 o3
10.4 
±1 » 8
14.3 
+0,96
38,6
+3.1
2.9.4
±4 » 1
26.3 -x-% 
+2.2
14.4
+3.1
16.0
+2,8
Right vent rid e
9.7
+1o9
9.0 
+0,88
7.0
+0,91
13.0 
+0,99
7.6
+1.3
6.3 
+1.6
9.4
+1.9
13.3
±0.94
13.0
±1.6
17.4
±3 o 2
18.3 -%-x- 
+2,6
13.6 
+3 * 1
12.3 
+2.4 
12,8 
+3.6
Lean + Slat, +p<0c05, **p<f0.01, 0.001
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SUMMARY AND CONCLUSION
1, The present investigation started from observat­
ions reported in the literature that in hypertrophy 
the myofibrils increase in diameter without a con­
comitant increase in blood supply as indicated by the 
number of capillaries and the diameter of coronary 
artery i.e. hypertrophy and impaired perfusion are 
usually concomitant,
2p Comparison of hearts which were markedly hyper­
trophic ^ but essentially well perfusedwith hearts 
which were poorly per fused,./out only moderately 
enlarged;made it apparent that the changes in LDH 
which have been thought characteristic of hypertrophy 
are really characteristic of poor perfusion,
3. Such poorly perfused hearts were also characterised 
by a high content of fibrous tissue which could be 
demonstrated both histologically and chemically. The 
LDH pattern of fibroblast in pure culture suggested 
that the altered LDH pattern in poorly perfused hearts 
may merely reflect their high content of fibrous tissue,
4. A survey of several metabolic enzymes in hyper­
trophy and poorly perfused hearts showed that in the 
latter there was a notable decrease in two mito­
chondria enzymes (malate dehydrogenase and NADP— 
dependent isocitrate dehydrogenase) which seemed too 
large to be explained merely by the change of the 
relative proportions of muscle cells and fibroblasts. 
This, if true suggested that poor perfusion with 
possible/...
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possible hypoxia might have brought about 
degeneration of the mitochondria, but it was 
dangerous to put too much confidence In enzyme 
patterns from autopsy material due to autolysis 
between death and post mortem dissection.
5, Hence, there was the need for experiments on 
animals,
6, The first and in some ways the most striking 
result obtained from these experiments was that, 
although in man cardiac hypertrophy develops slowly 
over months and perhaps years, in animals it can, 
by a variety of agents, be produced in a matter of 
weeks and even days, However the degree of 
hypertrophy that can be reached in man is never 
achieved in animals,
7, This experimental hypertrophy was characterised 
by the same change in LDH isoenzyme patterns with the 
same changes in fibrous tissue as the cardiac hyper­
trophy encountered in human autopsy material. When 
marked changes in LDH isoenzymes occurred they were 
accompanied by marked changes in amount of fibrous 
tissue (i.e. isoprenaline treatment)« When moderate 
changes in LDH isoenzymes occurred, they Lo'C were 
accompanied by moderate changes in fibrous tissue (i.e, 
coarctation of the aorta)» Or, when small changes in 
LDH isoenzymes occurred they were also accompanied by 
small changes in fibrous tissue, (i.e. thyroxine 
treatment). These results clearly establish that 
changes/...
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changes in the LDH isoenzyme pattern are closely 
related to the changes in fibrous tissue and are not 
associated with the new material which is added to 
the myocardial cell as a result of cardiac 
hypertrophy,
8. The fibrosis found in the hypertrophic hearts 
at autopsy or in experimental animals can most 
readily be explained on the assumption that it 
represents the replacement of damaged or destroyed 
myocardial cells. In an attempt to confirm or 
refute this supposition, CPK and LDH were determined 
in the blood serum of experimental animals in v/hich 
hypertrophy was being artificially induced. The 
levels of both enzymes showed modest, but unmistakable 
increases at precisely the time when destruction of 
muscle cells would have been predicted. Isoprenaline 
treatment led to an early increase in both of these 
enzymes which, during the latter stages of the 
experiment, return to the control. Thyroxine treatment 
led to progressive increases in both of these enzymes 
during the latter stages of the experiment. Coarct­
ation led to intermittent changes in both enzymes.
The changes in fibrous tissue more or less proceeded 
or occurred during these changes in serum enzymes.
9, If necrosis did indeed accompany or precede hyper­
trophy, it would be reasonable to suppose that lysosomal 
enzymes would play some role(though not necessarily a 
primary role) in the process of cellular necrosis. 
Estimation /..,
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Estimation of free lysosomal enzymes in the hearts 
of experimental animals did indeed show their 
liberation. The increase in free lysosomal 
enzymes following a single injection of isoprenaline 
was paralleled by an increase in serum CPK and LDH. 
This sort of parallelism remained throughout the 
experimental period. Thyroxine treatment led to 
progressive change in free lysosomal enzymes and a 
progressive change in both serum enzymes. Coarc­
tation of the aorta led to intermittent changes in 
free lysosomal enzymes and intermittent changes in 
both serum enzymes. This remarkable parallelism 
clearly establishes the association between myo- 
cardiac necrosis and lysosomal enzymes liberation. 
This clear picture however, was complicated by the 
fact that the bound forms of these enzymes also 
increased (with the exception of isoprenaline 
treatment where a single injection resulted in an 
increase in the free form and concomitant fall in 
the bound form). The increase in the bound form 
of lysosomal enzymes could most easily be explained 
on the assumption that the concentration of free 
and bound lysosomal enzymes in the heart as a whole 
were being altered as fibroblasts and macrophages 
displaced the necrotic muscle cells. Since these 
cells are rich in lysosomal enzymes they would 
obscure the true change in the ratio of bound to free 
lysosomal enzymes. Histochemical evidence did 
indeed/,,,
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indeed show that the lysosomal enzyme N-0Lcety 1-B- 
D-glucosaminidase was localized only in fibroblasts 
or cells of similar appearance. There also 
appeared to be more enzymes in these cells as 
compared to the control. However, histochemical 
evidence also showed that the enzyme acid phos­
phatase was increased in the myocardial cell. The 
increase in acid phosphatase suggested de novo 
synthesis which may be an alternate explanation of 
why the bound form of lysosomal enzymes increases
10. This question of whether hypertrophy was 
accompanied by a change in lysosomal activity in the 
myocardial cell proper was tackled by electron 
microscopy. The results of examining the hearts 
of experimental animals in the electron microscope 
showed, among other changes, abundant evidence that 
dense veiscles, which appeared to be tertiary 
lysosomes, were much more numerous in hypertrophic 
hearts than in normal hearts. Autophagosomes 
(secondary lysosomes)/ which were never seen in normal 
hearts/were frequently observed in the hypertrophic 
hearts. This seems strong circumstantial evidence 
for lysosomal activity in the myocardium during 
cardiac hypertrophy. Thhs, the increases in the 
bound lysosomal enzymes may represent two distinct 
processes; one which is related to change in the 
cell types; the other related to de novo synthesis 
of lysosomal enzymes,
11/.,,
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11. This evidence of cell destruction in the 
hypertrophic hearts of experimental animals was 
accompanied by an increase in rough sarcoplasmic 
reticulum in the myocardial cells. These results 
would tend to suggest increased protein synthesis 
in response to hypertrophy or cellular damage.
Also observed were increases in rough sarcoplasmic 
reticulum in fibroblasts, which may be related to 
collagen synthesis in response to myocardial 
necrosis.'
12. The least expected of the electron microscope 
findings was the abundance of lipid droplets in the 
hypertrophic myocardial cellsx These lipid 
droplets were quite often found within mitochondria 
and in such cases there was often a contiguous empty 
zone as though the cristae had been destroyed. It 
is hardly fanciful to see a connection here with the 
observations, noted above, that in hearts obtained
at autopsy the activities of two characteristic mito­
chondrial enzymes (malate dehydrogenase and NADP 
dependent isocitrate dehydrogenase), were consideraly 
depressed,
13. This association of lipid droplets with 
hypertrophy was confirmed histochemically and by 
chemical analysis. The increase in lipids might 
very well be explained by the parallel increase in 
serum free fatty acids. However, the accumulation 
of lipids may also be related to decrease in the 
oxidation/...
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oxidation fatty acids as a result of hypoxia or 
a decrease in carnitine. A decrease in carnitine 
has been associated with cardiac hypertrophy 
(Wittle and Spann, 19 68),
140 It should be emphasized that all the changes 
described above as associated V7ith experimental 
cardiac hypertrophy form a comiaon pattern quite 
regardless of the agency by which the hypertrophy 
was induced. This suggests that all the methods 
which were used to produce hypertrophy bring about 
some conuraon effect which triggers all the other 
changes. A possible candidate for this common 
effect is lactic acid, the concentration of which 
increases quite sharply in the hypertrophic myo­
cardium despite the fact that it diffuses so readily 
in and out of the cells. A local increase in 
lactic acid v;ould presumably produce a local fall in 
pH. This would be expected to result in the release 
of lysosomal enzymes, and they in turn might evoke 
the whole pattern of changes described above. Such 
an effect was observed following a single injection 
of isoprenaline. When the levels of lactic acid 
increase there was a concomitant increase in the free 
lysosomal enzyme and a decrease in the bound lysosomal 
enzymes. These changes were accompanied by an 
increase in both CPK and LDH. These results would 
appear to substantiate the above hypothesis.
15. The results described above, give a detailed 
and/..o
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and consistant description of the changes, chemical, 
histological and cytological, which take place in 
experimental cardiac hypertrophy. They also offer 
some reason for thinking that such experimental 
hypertrophy, in spite of its rapid development, 
resembles the slowly developing hypertrophy seen 
in human patients. But they throw little light 
on the sequence of cause and effect which leads from 
hyperfunction to hypertrophy and ultimately to 
failure. It is^however^quite clear that the 
hypertrophic heart is neither chemically nor morpho­
logically merely a large version of the normal heart. 
Corvisart^s celebrated comparison with the blacksmith's 
forearm is fundamentally false. Since the fine 
structure of the hypertrophic heart shows evidence of 
disorganization long before failure is clinically 
apparent. The dense vesicles and the autophagosomes 
which appear so early in the hypertrophic process 
can surely be related to the failure in which that 
process ultimately ends. Therefore, the processes 
of hypertrophy and degeneration must have a common 
origin,
16. It is this which distinguishes cardiac 
hypertrophy from most examples of what has been 
called "adaptive" growth. If part of the liver is 
removed the remainder grows until it is as large as 
the original intact organ (Bucher and Malt, 1971), 
Histologically and functionally this hypertrophic 
fragment is indistinguishable from normal liver, and 
it will sustain the animal perfectly adequately/...
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adequately throughout its normal life span. Again 
it is well known that if one kidney is surgically 
removed its partner slowly doubles in size. This 
enlarged single kidney seems to be an entirely 
adequate substitute for the original pair of kidneys.
Both these phenomena are presumably examples 
of an organ responding to a disproportionate 
functional load by increasing in size, The muscles 
of a blacksmith or an athlete are a more familiar 
example of the same phenomena. Even the heart can 
respond to exercise or hypoxia in the same way.
Why cannot it respond equally well to the overload 
imposed, say, by hypertension? Only a very 
tentative answer can be offered. One of the most 
striking and surprising findings of the present study 
v/as the high lactate concentrations in the hyper­
trophic hearts. This may indicate a degree of local 
hypoxias such hypoxia would not be unexpected given 
that heart muscle under normal circumstances extracts 
a very high proportion of the oxygen from the blood 
circulating through it. The continued unremitting 
exertion required to maintain a normal twenty-four 
hours a day cardiac output, against the increased 
aortic pressure of hypertension might be too much 
for the oxygen supply available to the myocardium.
If one accepts that hypoxia could be produced in 
this way, some at least of the changes found in the 
present study would find an explanation: not only
the/.,.
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the high lactate concentrations and the liberation 
of lysosomal enzymes; but perhaps also the 
accumulation of lipid ^ .which the hypoxic mito­
chondria^ which may be damaged^cannot utilise.
17. But all this is highly speculative. Whatever 
else may be said of cardiac hypertrophy, it is 
unquestionably a highly complex process. It seems 
unlikely that we shall establish its underlying 
mechanism until we know much more than at present 
about the way in which it manifests itself. The 
present study is, I hope, a small contribution to 
that endp
APPENDIX - METHODS AND MATERIALS
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METHODS
1) " General
1„1 Anlmcils g Male californian rabbits from the 
departmental colony were maintained on the diet of 
Short and Gammage (19 59) , The animals were housed 
in a temperature controlled unit, given water and 
food ad-libitum and used when these were three months' 
old and .weighed 2,500 to 2,800 g«
1,2 In j ection procedure :
1.21 Isoprenalines Isoprenaline sulphate 
was dissolved in 0.9% saline and injected subcutan­
eous ly at an initial dose of 1 mg/kg body weight, on 
the first day» On each subsequent day the dose was 
increased 1 mg/kg, so that on the 15th day the dose 
was 15 mg/kg body weight. Control rabbits were 
injected with 0.9% saline for 15 days.
1.22 Thyroxine: Sodium L-thyroxine was
dissolved in O.OIN NaOH, brought to pH 10 with
O.IN HCl and daily subcutaneous injections of 88 ug/kg 
body weight were administered for 15 days. Control 
rabbits were injected daily with 0.9% saline adjusted 
to pH 10.
All injections were performed at 11.00 a.m.
1.31 Coarctation of the abdominal aorta : 
Animals were anaesthetized with nembutal and a silver 
clamp (1 mm, in width) was placed around the descend­
ing aorta just beneath the diaphragm, according to 
the/..,
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the original method of Beznak (1958) , as modified by 
Kogan (1961). This procedure created a diminution 
of the transverse section of the aorta to about three 
fourtisof its original area. Sham operated animals 
were treated identically except that aortic con­
striction was omitted.
1.4 Autopsy material: Human cadavers at death
were placed in a refrigerator at 10°C until the 
attending pathologist performed the post mortem. 
Autopsies were generally performed within 7 to 2 4 
hours of death. The dissected hearts were rinsed 
with 0,25 M, sucrose, blotted and weighed. After 
weighing^the thickness of the left and right ventricular 
walls was recorded and the left ventricular free wall 
was removed and placed into ice cold 0,2 5 M, sucrose.
The subjects selected for this study were 
chosen as follows: Group 1 (the control) consisted
of patients without cardiac enlargement or coronary 
artery disease. Group II, consisted of patients who 
had sufferelmoderate cardiac hypertrophy and marked 
coronary disease as indicated by coronary artery 
narrowing with recent or old infarction. Group 111, 
consisted of patients with marked cardiac enlargement 
with or without moderate coronary artery disease.
The selection of the various groups was made by the 
attending pathologist from the Western Infirmary of 
Glasgow,
1.5 Weight measurements: Rabbits were killed by 
cervical/,.,
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cervical dislocation and their hearts were dissected 
out and flushed with 0,25 M. sucrose then blotted 
and weighed.
The left ventricle of the excised hearts 
was dissected according to the. procedure of Fulton 
et al, (1952), then blotted and weighed.
le-6 Wet and dry weights The dissected left 
ventricle was cut into small pieces, blotted and 
weighed and then placed on a clean weighed watch 
glass. The tissue was then dried in a hot air oven 
at lOO^C for 24 hours. The watch glass with the 
dried tissue was then reweighed. The weight of the 
dried tissue minus the weight of the watch glass was 
taken as the dry weight. While the difference in the 
original weight was taken as the wet weight.
2) Chemical Methods
2.1 Lactate dehydrogenase isoenzymes:
A) A 1 g sample of either the left or right 
ventricle was cut into thin slices and homogenised in 
20 ml. ice-cold 0.2 5 M sucrose using an "Ultra Turrax" 
(Janke and Kunkel KG, Stauffen i.BR., Germany) homo™ 
geniser (setting of 90). The homogenate was 
centrifuged at 20,000 xg for 20 minutes. The super­
natant was decanted off, diluted 1:50 and 10 ul 
aliquots were used to determine the LDH isoenzymes.
The same procedure was used for rabbits and 
human autopsy material, except for the left ventricular 
free wall from autopsy material where 4 g of tissue 
was/...
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was homogenised in 80 ml of 0.25 M sucrose.
MethodÏ
LDH isoenzymes were separated by disc gel 
electrophoresis on a 5.5% acrylamide/bis acrylamide 
gels as described by Dietz and Lubrano (1967). Gels 
were run in a Canalco chamber at O^C. A constant 
current (2.5 m.a. per tube) was maintained with a 
Beckman Duostat power supply. Isoenzyme separation 
was usually complete in 40 minutes. The separated 
isoenzymes were stained with, nitro-blue tétrazolium 
according to Van der Helm (1961). The isoenzyme 
content was quantitated using a Joyce-Lobel microdens­
itometer fitted with a photovolt gel scanner and an 
integrator to measure the area under each peak.
Helu cells:
(Human embroyoic lung cells oK fibroblast) of 
the fourth passage were kindly supplied by the tissue 
culture unit of the department of Biochemistry, Glasgow
Approximately 10^ cells were suspended in ice- 
cold 0.25 M sucrose and centrifuged at 300 x £ for 20 
minutes and the supernatants were decanted. This 
process was repeated three times. After the third 
wash the cells were suspended in ice-cold 0.25 M 
sucrose and homogenized using a Dounce (B) homogeniser 
by ten up and down strokes. The homogenate was 
centrifuged at 20,000 x £ for 20 minutes. The super­
natant was used to measure the LDH isoenzymes as 
described above,
2 .2/...
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2.2 Tissue lactic acid determination: Samples
of the left and right ventricles were quickly removed, 
weighed and frozen in liquid nitrogen. The liquid 
nitrogen was allowed to evaporate and 5 ml.of ice- 
cold perchloric acid (6% w/v) was added to the frozen 
tissue. The tissue was homogenised using an "Ultra 
Turrax" homogeniser {setting of 90) for 4 minutes at 
0°C. The homogenate was centrifuged at 600 x g for 
15 minutes. The residue was re-extracted with 3 ml. 
of ice-cold perchloric acid and again centrifuged as 
described above. The supernatants were combined and 
neutralized with 5 M potassium carbonate, (approximately 
0.2 ml) using 0.02 ml. of methyl orange as indicator. 
This solution was allowed to stand in an ice-bath for 
10 minutes, then centrifuged at 600 x £ for 10 minutes. 
The resulting supernatant was used to determine lactic 
acid by the method of Hohorst (1959).
2.3 HydroXVpro1ine estimations Dried tissue (0.1 
to 0,5 g) from the left ventricle was hydrolysed with 
3 ml. 6N HCl for 24 hours in sealed test tubes at 
105^C« After hydrolysis, humin was removed by 
filtration. The resulting suspension was dried using 
a rotary evaporator and diluted to a known volume. 
Aliquots of 2 ml. (1-5 ug hydroxyproline) were taken 
for the determination of hydroxyproline by the 
modified Stegeman (1958) method described by Woessner
(1961), Hydroxyproline was also measured using the 
Beckman amino acid auto analyzer according to the 
method/.,,
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method of Benson et al, (1965) and Spackman et al, 
(1958)o
2,4 Hexosamine estimation: Dried tissue (0.1 to
0.2 g) from the left ventricle was hydrolysed in 5 ml. 
2N HCl and heated at 95°C for 5 minutes in screw 
capped cultured tubes. The tubes were then flushed 
with nitrogen, sealed with teflon-lined caps and 
heating at 9 5°C was continued for a further 3 hours. 
Following this the tissue was broken™up with a 
stirring rod and the tubes were again flushed with 
nitrogen, re-sealed and heated at 95^C for a further 
15 hours. After hydrolysis, humin was removed by 
filtration and the hydrolysate was diluted to a known 
volume o
Aliquots of 2 ml. (equivalent to 5#50 ug of 
amino sugar) were taken for the determination of total 
hexosamine by the method of Cessi et al (19 60).
2.5 Protein estimation: Protein was estimated
according to the method of bowery et al (1951) except 
that sodium citrate was used instead of sodium 
potassium tartrate as it gives a more stable reagent 
(Eggstein 1955).
Standard curves were prepared using 10-100 ug 
of Bovine serum albumin (Fraction IV) in the 
appropriate homogenising medium.
2.6 Lipid extraction: Lipid were extracted using 
the method of Folch, Lees and Stanley (195 6).
Approximately 1 g portion of the left ventricle
was/...
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was cut into small slices and placed in a volumetric 
flask containing 20 ml. of chloroform-methanol 
(2:1 v/v)o After homogenising for 8 minutes using 
an "Ultra Turrax" homogeniser (setting of 120) the 
homogenate was filtered through Whatman No. 1 paper 
into a glass stoppered test tube. The residue was 
re-homogenised in 10 ml of chloroform-methanol 
mixture and again filtered. The combined extracts 
were shaken with 6 ml 0,9% saline and the two phases 
separated by centrifugation at 400 x £ for 30 minutes.
The upper phase was aspirated off and the 
lower phase rinsed three times with 4.5 ml of a 
chloroform-methanol-water mixture (3:48:47 v/v).
After each rinse the two phases were allowed to 
separate and the upper phase was removed by aspiration. 
The lower phase was finally evaporated to 
dryness at 37^0 under a steam of Nitrogen,
After drying the sample was taken up in 7 ml 
of pure chloroform filtered and brought to a final 
volume of 10 ml.
Total lipids was measured by pipeing 
2 ml aliquots of the chloroform extract in weighed 
tubes, evaporating the chloroform by heating at 37°C 
for 4 hours and determining the weight of the residue.
2.7 Glycerol estimation: A 2 ml sample of
chloroform extract was evaporated to dryness at 37^0 
with a steam of nitrogen. The residue was saponified 
in centrifuge tubes for 30 minutes in a 70% water bath, 
using/...
’”89“”
using 0.5 ml of 0.5N alcoholic potassium hydroxide. 
After saponification 1 ml of 0,15 M magnesium sulphate 
was added and the content of the tubes were mixed and 
centrifuged. Glycerol was then determined using 0,5ml 
aliquots of the clear supernatant.
Boerhinger kits were used to measure glycerol, 
according to the method of Eggstein et al (19 56).
Myocardial enzymes
Method of extraction: A 1,5 g sample of the
left ventricular free wall from human hearts obtained 
at autopsy was rinsed with ice-cole 0.25 M sucrose and 
blotted. It was then cut into small slices 'and 
homogenised using an "Ultra Turrax" homogeniser, 
(setting of 85), for 5 minutes in 10 ml of ice-cold 
0.25 M sucrose buffered with 0.005 M triethanolamine 
pH 7o5. The homogenate was centrifuged at 14,000 x g 
for 30 minutes at O^C. The supernatant v/as decanted 
and the residue re-extracted with 5 ml of the same 
buffered medium. The two supernatants were combined 
and used for measuring enzyme activity.
3,2 Estimation of enzyme activity
3.21 Glutamate - oxaloacetate transaminase
E.G. 2.6,1.1: Glutamate-oxaloacetate transaminase
(GOT) catalyses the reaction:
L-Glutamate t oxaloacetate L-aspartate +
O/oxoglutarate.
The activity of the transaminase was measured 
by the increase of oxaloacetate with time. The 
oxaloacetate/,,.
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oxaloacetate was determined with the indicator 
reaction catalysed by malate dehydrogenase (MDH).
Oxaloacetate + NADH 4- H^^^rmalate + NAD^
The oxidation of NADH, which is proportional 
to the amount of oxaloacetate formed, was measured 
by decrease in the optical density at 340nm.
In addition to enzyme the reaction mixture 
contained :
1) O.IM phosphate buffer pH 7.4_
0.04M L-Aspartate
2) 0,012 M NADH
3) 0.25 mg each of MDH and LDH/ml,
4) 0,25 M oxoglutarate
The description for measuring GOT is 
essentially that of Karmen (1955),
3.22 Creatine phosphokinase: E,C, 2.7,3,2:
The basic forward reaction catalysed by creatine
phosphokinase (CPK) was coupled to a dehydrogenase
reaction as can be seen from the following. This
method is essentially that of Tanzer Gilvarg (1959).
CPK
Creatine phosphate H- ADP Creatine + ATP
hexokinase
ATP 4- Glucose Glucose-6-phosphate + ADP
G-6-PDH
Glucose-6-phosphate + 6™phosphogluconase +
NADPH + H*^
An increase in optical density at 340 nm per 
unit or time was a measure of CPK activity Glutathione 
was used as an activator in this reaction.
In addition to enzyme the reaction mixture 
contained/,,,
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contained:
1) 0.11 m triethanolamine buffer pH 
7.0; 22 mM glucose; 11 mM Mg- 
acetate; 1.1 mI4 ADP; 11 mM AMP;
0.65 mM NADP.
2) 1 mg Hexokinase/ml; 1 mg Glucose- 
6-phosphate dehydrogenase/ml.
3) 0.2 5 M glutathione.
3.23 Malate dehydrogenase: E.G.1.1.1.37: 
Malate dehydrogenase (MDH) catalyse the reaction:
L-Malate + MAD oxaloacetate f NADH H^
The amount of oxoloacetate converted per unit 
of time as determined by the decrease in the optical 
density of NADH is a measure of MDH activity (Ordell, 
1957) .
In addition to enzyme the reaction mixture 
contained;
1) 0.01 M phosphate buffer pH 7.4;
0.042 M aspartate
2) 0.085 M oxoglutarate
3) 0.031 M NADH
4) 0.1 mg Glutamatic-oxaloacetate
transaminase/ml.
3.24 Glucose-6-phosphate dehydrogenase;
E.C.1.1.1.49.
Glucose-6-phosphate dehydrogenase 6-6-PDH
+catalyses the reaction. Glucose-6-phosphate + NADP ;
+
6-phosphogluconate t NADPH + H „
The/...
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The increase in NADPH at 340 nm is a measure
of the enzyme activity. The method used to measure
G-6-PDH is that of Schmidt et al (1958)„
In addition to enzyme the reaction mixture
contained:
1) 0o05 M triethanolamine buffer pH 7,6;
0.005 M ethylenediamine-tetraacetate
2) 0,01 M NADP
3) 0.031 M glucose-6-phosphate
3.25 Lactate dehydrogenase: E.G.1.1.1,27 
(LDH) catalyses the reaction:
pyruvate t NADH -f lactate + NAD
The activity is measured by the rate of con­
sumption of pyruvate and NADH. The decrease of 
optical density at 340 nm is due to the oxidation of 
NADH. The method used is that of Wroblewski and La 
Due (1955).
In addition to enzyme the reaction mixture 
contained;
1) 0.05 M phosphate buffer pH 7.5?
0.00031 M pyruvate
2) 0.009 M NADH
3.2 6 Isocitrate dehydrogenase: E.C,1.1.1.42 
The enzyme ICDH catalyses the hydrogen transfer reaction; 
Isocitrate + NADP^^oxoglutarate + CO^ + NADPH + H**".
The ICDH activity is determined from the ratd 
of increase of absorption at 340 nm due to NADPH pro­
duced by the reaction. The method is that of Wolfson 
et/..«
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et al (19 57).
In addition to enzyme the reaction mixture 
contained :
1) 0,1 M triethanolamine buffer pH 7.5;
0.004 6 M DL isocitrate; 0.052 M NaCl.
2) 0.0091 M NADP; 0.12 M MNS04
Ail the enzyme activities listed above were 
determined using the test combination kits manufactur­
ed by the Boehringer Corporation London Ltd.
Appropriate dilatations of the supernatant were 
made with the stock buffer to ensure that all reactions 
were linear with time.
The reactions were carried out in 3 ml silca 
cuvettes with a 1 cm ligh path. The course of the 
reaction was followed on a unicam S-P 500 series-2- 
spectrophotometer with a S-P 508 programme controller 
and a thermostatically controlled cuvette carriage.
4) Serum Studies
4.1 EXtraction method: A small cut was made into
the marginal ear vein of californian rabbits and the 
blood was allowed to flow freely into test tubes which 
were chilled in an ice-bath. The blood was then 
centrifuged at 600 x g at O^C, and the serum removed 
and placed in an ice-bath. Analyses were carried out 
with a minimum of delay after blood samples were 
withdrawn.
Blood samples were always drawn two hours 
after the injections (normally 11 a.m.) of isopren­
aline/. , .
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isoprenalinef thyroxine or saline. Samples of blood 
were drawn at 11 a.m. each day following aortic 
constriction.
4.2 Serum enzyme activities: Serum creatine
phosphokinase and lactate dehydrogenase were measured 
using Boehringer test kits as previously described.
Enzyme activities were expressed in the units 
of enzyme activity, (u) recommended by the International 
Union of Biochemistry. Thus, one unit of any enzyme 
is that amount which will catalyse the transformation 
of 1 micro mole (u mole of substrate per minute under 
standard conditions)„ 1 milli-unit (mu) = O.OOlu*
4.3 Serum free fatty acids: Serum free fatty
acids were extracted in chloroform. After extraction 
the amounts of free fatty acids was measured according 
to the method of Duncomb (1962).
5) Attempted Isolation of muscle cells
The left ventricle of a rabbit was removed and 
cut into small slices (1 mm thick). The slices were 
then incubated in Krebs-Ringer bicarbonate medium pH
7.4 which contained 0.40% collagenase and 0.15% hyal- 
uronidase for 0-4 hours at 37°C. After this period 
of incubation the suspension was carefully removed 
from the' undigested section and placed on a serum 
gradient (20-50%). The cells were allowed to sediment 
under gravity, fractions were collected and centrifuged 
100 X g for 5 minutes. The resulting pellets were 
examined under a light microscope to determine the 
purity/...
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purity of each fraction.
6) Myocardial lysosomal enzymes
6.1 Method of homogenisation: Hearts removed 
from rabbits were rinsed with ice-cold 0.25 M sucrose 
to remove any residual blood. Sample of the left 
and right ventricles were cut into small slices and 
homogenised using an "Ultra Turrax" homogeniser 
(setting of 42) for 15 seconds in ice-cold 0,25 M 
sucrose (1,5 g of tissue/10 ml). This suspension 
was re-homogenised using a Dounce (A) homogeniser 
using 3 up and down strokes. This homogenate was 
centrifuged as shown in Fig, 24,
The supernatant from the second centrifug­
ation was called the S-fraction and the activity of 
the free or soluble enzymes was determined in this 
fraction. The 20,000 x £ pellet was resuspended in 
10 ml, of 0,2 5 M sucrose and was called the L-fraction, 
The release of particulate lysosomal enzymes in this 
fraction was brought by freezing and thawing ten times 
or by addition of triton-x-lOO to a final concentrat­
ion of 0.14%. Triton-x-100 was found to have a 
greater effect on the release of lysosomal enzymes 
(Table 3§).
The above homogenisation scheme was chosen 
based on the distribution of lysosomal enzyme 
activity (Table 3g.J .
6.2 Estimation of enzyme activity: Ten lysosomal 
hydrolase were measured on the S and P fraction, eight 
of/...
Fig, 2 4
Method of separating bound and soluble lysosomal enzyme.
Heart Homogenate
I
pellet
discarded
pellet
resuspended in 0.25 M sucrose 
"L"
pellet
resuspended in 0.25 M sucrose
"M"
800 g
10 minutes
supernatant
20,000 X £  
30 minutes
supernatant
80,000 X £  
60 minutes
supernatant "S
Xj = lysosomal fraction 
M = microsomal fraction 
S = supernatant
TABLE 3#
The effect of triton-'X-lOO and freezing and thawing on the 
release of enzyme from 20,000 x pellet*
ihiK.pnes
B-D-Galactosid as e
it'
lucuronidas e
it
K-Acetyl-B-dMJ-lucosajninidase
-B-Marmc s i.das 0 
#
B“I)“G lue o s i das e 
Esterase
Acid deoxyribonuclease
Acid phosphatase 
-%
PhosphodiesterasejÀT
it
Cathepsin 3D
it'it-X'
Triton-x-100
0.50
J.0TG19
0.51
+0.061
1.41
+0*049
0c^6
+0*014
0.43
+0*021
1*82
+0*110
0.30
+0.010
1.9
+0*135
0.60
+0*048
19
+1.9
Mean + SEM 
•4 cs mu moles phenol/minute/mg protein
= increase in optical density (unit 
rag protein 
itiHt =. ug tyrosine/ 30 minutes/rag protein
Freezing and thav/ing 
(10 times)
0.34
+0.010
0.50
+0.018
I0OO
+0,063
0.40
+0*023
0.44
+0.016
0.90
+0*086
0.21
+0.016
1,9
+0*199
0*61
+0,063
16
+2*1
0.100 01)) per hour/
TABLE 32v
lysosomal enzyme distribution in the left ventricle of californian 
rabbits, AXz. c>‘m T r \ l a C i
?]n;^ ymes Lysosomal Microsomal Supernatant
B-D-Oalactosidase 0.50 0.05 0.34
+0.016 ' +0.001 +0.010
B“D“-Cr Incur oni das e 0.40 0 0.40
'X' +0.020 +0.016
N-Acetyl-B-B'-’G-lucosaminidase 1,4 0.11 0.63
•K- +0.046 +0.014 +0.023
“B- Mannosidase 0.40 0 0.29
# +0*009 «» +0.013
B-B-'Glucosidase 0 « 44 0 0.19
*?{• +0.011 +0.006
Esterase 1.0 0.30 0.81
+0.194 ±0.006 +0.073
Acid deoxyribonuclease ^ 0.30 0 0.25
it-K- ±0.008 — +0.013
Acid phosphatase 1.9 0.9 2.1
it +0.164 +0.094 +0.187
Phosphodiesterase J-hl 0,60 0.05 0.63
+0.035 +0.009 +0 s 046
Cathepsin D 16 0 16
+1.6 n +1.3
Mean + SEIvî
it- « mu moles phenol/minute/mg protein
 ^increase in optical- density (unit - 0*100 OD) per 
hour/mg protein
i-K-it ~ ug tyrosine/30 mi nut es/mg protein
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of them were measured using the automated method of 
Bradley et al (1964) modified as detailed later, the 
other two were measured manually*
6*21 Manual method:
1) Acid deoxyribonuclease E.C, 3.1*4.6 
In this reaction deoxyribonucleic acid v/as 
hydrolyzed by acid deoxyribonuclease to various 
oligonucleotides and mononucleotides. The products 
of this reaction were then measured spectrophotometri- 
cally at a U.V. absorption of 260 nm. The method used 
in this study was that of de Duve et al (19 55)*
In addition to enzyme each reaction mixture 
contained:
0.05 M acétate buffer pH 5.0 and 2,5 mg 
of denatured DNA,
Cathepsin D : E.C, 3.4.4.23
The hydrolysis of acid-denatured haemoglobin 
was used to measure the activity of cathepsin D, The 
aromatic degradation products were measured by means 
of the Polin-Ciocaltease reaction as described by 
Anson (1939). The exact method used to measure 
cathepsin D was that of de Duve et al (1955) .
In addition to enzyme the reaction mixture 
contained:
2% denatured haemoglobin in 0.1 M 
lactate Buffer pH 5.0.
6.22 Automated method: Eight lysosomal
enzymes were measured using an automated method. The 
principle/,..
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principle involved the hydrolysis of p-Nitrophenyl 
substrates to p-Nitrophenol, The p-Nitrophenol 
was developed in base to give a yellow colour, the 
absorbance of which was measured at 420 nm. The 
conditions chose6^i,e, substrate concentration and 
pH were essentially those reported by Bradley et al 
(1964) Table and were not radically different 
from those of the manual method (Tappel 1968^ 
Comprehensive Biochemistry),
Procedure % From the sampler II substrate and 
enzyme were simultaneously sampled through separate 
lines. The solutions were passed through a 
peristaltic pump (pump II technicon) and then 
connected to a mixing coil on the effluent side before 
the stream was segmented with air bubbles. The 
segmented stream passed into a heating bath and under­
went incubation for a period of time proportional to 
the flow rate and heating bath column volume. This 
was usually 10 minutes. On the effluent side of the 
bath the reaction mixture was mixed with 1.9 3 M NH^ OH 
pH 10.7 to terminate the reaction. The solution then 
passed through a filter and the chromophoric product 
was determined in a flow cell colorimeter. The 
absorbance at 420 nm was recorded on a strip chart 
(Fig. 25).
A one minute buffered wash (0.001% triton -x- 
100 in 0.01 M acetate buffer pH 5,0) followed each 
test sample.
Enzyme/...
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Fig. 25 Flow diagram for the
determination of eight 
lysosomal enzymes.
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Enzyme and substrate blanks were run 
° separately and their absorbance values were sub­
tracted from those of the test sample. In addition 
p-Nitrophenyl standards (0-20 ug in 1,93 M NH^ OH 
pH 10.7) were run daily for calibration.
This method incorporated the following 
modifications of the original method of Bradley 
et al (19 54)«
1) System for filtering: Measurement of
enzyme activity on the 20,000 x £ pellet after re­
suspension and homogenisation, proved difficult due 
to the formation of a precipitate during incubation 
of substrate and enzyme. This precipitation often 
obscured the enzyme activity. Apparently this 
problem was not encountered by Bradley et al (1964) 
using liver. However, the low levels of lysosomal 
enzymes in heart tissue necessitate the use of 
larger amounts of tissue.
The introduction of system to filter the 
reaction mixture, (detailed in Fig. 26) prior to its 
entering the recorder resolved this proglem. Fig, 27 
illustrates the results before and after this system 
was introduced.
2) The second modification involved introduc­
ing substrate and enzyme simultaneously as described 
in Fig. 2 8a. This was incorporated due to the cost 
of two technicon samplers. Bradley et al (1964) had 
found that the simultaneous introduction of substrate 
and/,..
Fig. 26 a) Details of filter:
1) unfiltered enzyme and 
substrate mixture:
2) wire mesh used to filter 
enzyme substrate mixture.
3) filtered substrate and 
enzyme mixture.
b) Top view of filter.
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Fig. 2 7 a) The direct recorder readout
of eight lysosomal enzymes 
after introducing the filter.
b) The direct recorder readout 
of eight lysosomal enzymes 
before the filter was intro­
duced.
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and enzyme often led to ill defined peaks* This 
" difficulty V7as not experienced in the present work.
3) An ice-'cold water bath was fitted onto
the sampler II to keep the enzyme and substrate cold
prior to their mixing (Fig* 2 8b)*
7) Histochemical studies
7ol Histological examination for collagen and 
mucopolysaccharides *
A section of the left ventricle was removed 
as quick as possible and placed in 10% buffered formol 
solution (Lillie 1954)* After fixation^ usually for 
24 hours, sections were dehydrated through increasing 
alcohol, embedded in paraffin and sections were 
cut, stained and mounted on glass slides.
The left ventricular free wall from human
autopsy was divided into three parts, anterior, 
posterior and lateral* The 6p. sections from each 
part were stained for collagen using the Masson 
trichrome strain as described by Masson (1928)*
After staining, sections were examined under 
a binocular Watson Barnett light microscope (mag­
nification X 100) to determine the relative pro­
portions of muscle cells, fibrous tissue (i.e. 
collagen and fibroblast and other cellular elements 
i.e. blood and endothelial cells), in each section. 
This was done by inserting a grid into one of the 
eyepieces of the light microscope. Twenty-five 
fields were examined in each section noting in each 
field/.*,
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field how many grid intersections fell upon muscle 
cellf fibrous tissue and other cellular elements*
There were 6 4 possible intersections in the grid 
used for this study* In some rabbit experiments 
three serial sections were made of the left ventricle; 
one was stained with Hematoxylin eosin, (as described 
by Schleider 19 5 3); one with Masson trichrome, and 
one V7ith Hale colloidal iron stain (as described by 
Hale 1946).
Hale stain gave a blue colour for acidic 
mucopolysaccherides, while Masson trichrome stain 
gave a green colour for collagen*
7.2 Histochemical examination for, acid 
phosphatase, N-flLcetyl-B-D-^lucosaminidase and lipids.
A section of the left ventricle of 
Californian rabbits were cut into 1 mm slices and 
fixed in formol calcium fixative containing 4% w/v 
formaldehyde and 1% anhydrous calcium chloride for 
24 hours at 4^C. Without washing, the tissue was 
blotted on filter paper and transferred to hyper­
tonic gum sucrose medium, (0.88 M sucrose containing 
1% gum acacia) for 24 hours at 4^C (Holt, 1959). A 
5u section was then cut using a cold microtome as 
described by Adamstone and Taylor (1948). The 
sections were stained as described below and mounted 
in glycerine jelly on glass slides,
7,21 Acid phosphatase : In the above sections 
were demonstrated according to the method of Gomori 
(1952)/..
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(1952)*
Principle : The substrate Na-B-Glycero™
phosphate is hydrolysed releasing phosphate groups 
which immediately combine with lead i ons. Lead 
phosphate is insoluble in water and precipitates in 
the tissue at sites of enzyme activity* The colour­
less precipitate is converted to lead sulphide using 
hydrogen sulphide, which forms a brown or black stain*
7.22 N-Acetyl-B-"D-Glucosaminidase was 
measured according to the method of Hayashi (1964).
Principle : The substrate Naphthol-AS-Bl-N-
Acetyl-B-D-Glucosaminide (7-bromo™3-hydroxy-2- 
Naphth-O-anisidine) is hydrolysed releasing naphthol 
which combine with p-rosaniline at the site of enzyme 
activity. The reaction product appears red at the 
sit of enzyme activity.
7.23 Lipids were stained using either Sudan 
Black B as described by Chiffelle and Putt (1951) or 
Oil Red "0" according to Lillie (1944). Sections 
stained with sudan black B were counter-stained with 
haemalum while those sections stained with Oil Red "0" 
were counter-stained with Nuclear fast green.
8) E1ectron Microscope Studies
Portions of the left ventricle (1 mm thick) 
were fixed in ice-cold 2.5% gluteraldehyde in 3% sucrose 
buffered with 0.1 M sodium cacodylate at pH 7.2 for 
2 hours; washed with cold 6% sucrose buffered with 
0.1 M sodium cacodylate pH 7.2 for 2 hours; post­
fixed/. . .
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post fixed with cold 1% osmium tetroxide in 5% sucrose 
' buffered with 0*1 ftl sodium calcodylate pH 7*2; 
washed in the above buffered sucrose; dehydrated in 
ethanol and propylene oxide and embedded in aralditOo 
Silver-gray sections, cut with glass knives 
on a ultra-microtome and suspended on 200 mesh copper 
grids, were stained with uranyl (saturated solution) 
and lead citrate (3% solution), and examined with 
AEl EM6 and EM6B electron microscope.
9) Statistical Method
In the experiments in which statistical 
analysis was performed, results v/ere analysed by the 
students' t-test. The expressions p(0*o5 and
p40.01 are used in the conventional sense to indicate 
significance at the 5 per cent and 1 per cent levels 
respectively.
Materials
All chemicals when possible, were "analar 
grade" or its equivalent; substrates for lysosomal 
enzymes, nitro blue tétrazolium, methyl phenenazonium 
and Methosulphate, Collagenase and Hyaluronidase, 
Bovine serum albumin (Fraction IV), Glucosamine, were 
obtained from SIGMA Chemical Co. London; isoprenaline 
and thyroxine was obtained from Burroughs Wellcome 
Co. London,
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